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Fetal alcohol syndrome (FAS) refers to the characteristic anomalies found in the 
children born to alcoholic women. It is composed of facial dysmorphology, pre- and 
post-natal growth retardation and central nervous system (CNS) abnormalities. FAS is 
one of the leading causes of mental retardation in the western world. In the United States 
alone, more than 1200 children are born with FAS each year (Abel and Sokol, 1991). 
As children grow, facial abnormalities and retarded growth become less marked. 
However, CNS abnormalities, especially abnormal behavior, learning and memory 
deficits, and mental retardation, become persistent devastating problems. 
During the last 20 years, neuroanatomical and neurochemical studies in animal 
models of FAS have been performed in order to understand the underlying causes of 
abnormal behavior and mental retardation. These studies have shown that many brain 
structures and major neurotransmitter systems were abnormally developed. The 
serotonergic system, one of the most expansive neurotransmitter systems in the brain, has 
been shown to be affected by in utero ethanol exposure at the level of the concentrations 
of the neurotransmitter and its metabolites, uptake sites and certain receptors (Rathbun 
and Druse, 1985; Druse et al., 1991; Druse and Paul, 1989; Tajuddin and Druse, 1989). 
However, the mechanism by which ethanol acts on the developing serotonergic 
system is unknown. The purpose of this dissertation is to assess two potential underlying 
2 
mechanisms by which in utero ethanol exposure contributes to the abnormal development 
of the serotonergic system. (1) The decreased serotonin (5-hydroxytryptamine, 5-HT) 
content in ethanol-exposed fetuses (Druse et al., 1991) could lead to decreased 
stimulation of raphe 5-HT1A receptors and astroglial 5-HT1A receptors. Decreased 
stimulation of raphe 5-HT1A receptors may result in altered development of serotonergic 
neurons. Decreased stimulation of astroglial 5-HT1A receptors leads to decreased 
production of neurotrophic factors for fetal 5-HT neurons (Azmitia et al., 1990; 
Whitaker-Azmitia et al., 1990). (2) In addition, a generalized decrease in astroglial 
protein synthesis and content (Guerri et al., 1990; Snyder et al., 1992) could lead to 
decreased production of important astroglial growth factors, which are essential for 
neuronal growth and differentiation. Thus, the hypothesis of this dissertation is that part 
of abnormal development of serotonergic system caused by in utero ethanol exposure 
may be due to in part a decreased level of essential growth factors such as serotonin 
and/or astroglial-derived growth factors. 
In order to examine this hypothesis, an in vivo animal model and in vitro cell 
culture studies were used. In the in vivo rat model, quantitative autoradiographic studies 
were performed. Specifically, I examined the effects of in utero ethanol exposure on the 
extent of abnormalities in 5-HT reuptake sites and 5-HT1A receptor sites in offspring. In 
addition, I assessed the possibility that maternal treatment with a 5-HT1A receptor agonist, 
buspirone, could prevent abnormalities involving 5-HT reuptake and 5-HT1A receptors in 
ethanol-exposed rats. In in vitro cell culture studies, the effects of ethanol treatment on 
the production of astroglial-derived growth factors were studied. Conditioned media from 
3 
control and ethanol-treated astroglia were used to culture fetal serotonergic neurons. The 
effects of the conditioned media on the growth of serotonergic neurons was determined. 
CHAPTER II 
REVIEW OF RELATED LITERATURE 
Fetal Alcohol Syndrome (FAS) 
Human Studies 
A characteristic pattern of anomalies was found in children whose mothers 
chronically abused alcohol during pregnancy. These symptoms were described as FAS 
(Jones and Smith, 1973). FAS is characterized by facial dysmorphology, growth 
deficiency and signs of CNS dysfunction (Jones et al., 1973; Clarren and Smith, 1978; 
Clarren et al., 1978; Kyllerman et al., 1985; Aronson et al., 1985; Streissguth et al., 
1988). It has been recognized that all infants exposed to prenatal alcohol may not develop 
the full spectrum of symptoms. Affected infants may show symptoms ranging from mild 
to severe. The lesser affected infants may be described as having fetal alcohol effects 
(FAE). The facial abnormalities in FAS include malformations in the major components 
of the face: short palpebral fissures, low nasal bridge, upturned nose, indistinct philtrum, 
thin upper lip, and flat midface (Jones and Smith, 1973). Malformations of other organs 
also occur in the children with FAS. These include cardiac, genital and renal 
malformations (Sandor et al., 1981; Clarren and Smith, 1978). The growth retardation 
of FAS children exhibited by decreased weight, height and head circumference, starts 
4 
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prenatally and persists throughout adolescence (Clarren and Smith, 1978; Golden et al., 
1982; Streissguth et al., 1985). Intrauterine growth retardation is directly proportional 
to the degree of maternal alcohol intake (Streissguth et al., 1980). 
There are a number of CNS abnormalities associated with FAS. Microcephaly, 
reflecting deficient brain growth, has been observed in greater than 80 % of children with 
FAS. The microcephaly has a prenatal onset and becomes quite apparent as the child 
matures (Clarren and Smith, 1978). Neural tube defects such as anencephaly and 
meningomyelocele also occur at a higher rate in FAS children (Freidman, 1982). Other 
neurological abnormalities such as altered cerebellar function, hypotonicity and increased 
incidence of cerebral palsy and seizure are also found in FAS children (Burd and 
Martsolf, 1989; Hanson et al., 1978; Olegard et al., 1979). Behaviorally, newborns born 
with FAS usually show irritability, tremulousness, and poor suckling and eye-hand 
coordination (Golden et al., 1982; Hanson et al., 1976). Young children with FAS show 
hyperactivity, emotional instability, and poor motor skills and eye-hand coordination 
(Aronson and Olegard, 1987; Harris et al., 1993; K yllerman et al., 1985; Steinhausen 
et al., 1993). In addition, FAS children have higher rates of speech and language 
problems and visual-perceptual problems (Aronson et al., 1985; Greene et al., 1990). 
Mental retardation is one of the most common and serious problems associated with in 
utero ethanol exposure. IQ studies of FAS children showed an average score of around 
65 with a range from 16 to 105 (Streissguth et al., 1988). There is a close association 
between the severity of physical abnormalities and the severity of intellectual deficits. 
However, brain malformation and intellectual deficits also occur in the absence of 
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detectable physical abnormalities in the offspring of moderate drinking mothers (Clarren 
et al., 1978; Peiffer et al., 1979; Conry, 1990; Streissguth et al., 1990). 
Animal Studies 
In human studies it is extremely difficult to separate the effects of alcohol from 
other complicating factors because chronic alcoholic women are frequently malnourished, 
are heavy smokers, and may abuse other drugs (Abel, 1984). These factors could also 
independently affect the fetal development. Animal models make it possible to control 
the compounding variables of human research. Among the animal species, mice and rats 
have been popularly used to study fetal alcohol effects because of their inexpensiveness 
and short gestation periods. 
Ethanol is administered in animal models using a number of different methods. 
Alcohol has been administered in drinking water (Borges and Lewis, 1982), in a liquid 
diet (Barnes and Walker, 1981), by vapor inhalation (Phillips and Cragg, 1982) or by 
stomach intubation (Abel et al., 1983; West et al., 1981). Since most animals do not 
voluntarily consume sufficient quantities of ethanol to obtain and sustain blood alcohol 
levels comparable to those of human alcoholics, administration of alcohol in drinking 
water is considered the least preferable procedure. By the intubation method high blood 
alcohol levels can be achieved. However, the procedure is stressful and may cause an 
irritation of the gastrointestinal tract, which leads to inhibited absorption of essential 
nutrients. The intubation procedure has been reported to significantly reduce maternal 
body weights compared to rats given the same quantity of alcohol by liquid diet (Vorhees 
7 
and Butcher, 1982). This may have an adverse effect on fetal development that is 
unrelated to the direct effect of ethanol. Therefore, the most appropriate method seems 
to be a liquid diet procedure which is not stressful to the animal and provides stable 
intoxicating blood alcohol levels as well as adequate nutrition. In addition, this method 
allows one to control alterations of food intake by using a pair-feeding paradigm. 
In the rat model of FAS neonatal alcohol exposure has also been studied because 
the first postnatal week of the rat pups is equivalent to the third trimester in humans. 
This time period corresponds to the brain growth spurt (Dobbing and Sands, 1979). 
Postnatal alcohol exposure in rats has been accomplished using a variety of techniques: 
through the milk of lactating alcohol-consuming mother (Abel, 1974), through gastric 
intubation (Diaz and Samson, 1980) and artificial rearing (Bonthius and West, 1990; 
Grant et al., 1983). The artificial rearing technique seems to be the best because it allows 
stable blood alcohol levels and adequate nutrition. This technique involves maintaining 
the rat pup in a cup which floats in the 37°C water bath. Alcohol-containing milk formula 
is infused into the pup through an implanted intragastric feeding tube. 
Many of the symptoms seen in human infants prenatally exposed to alcohol, have 
also been found in animal models of FAS (Chernoff, 1977; Randall et al., 1977). These 
include microcephaly (Tze and Lee, 1975; Randall et al., 1977; Lancaster et al., 1982; 
Miller, 1987), hyperactivity as measured in the open-field (Bond and DiGiusto, 1976, 
1977; Branchey and Friedhoff, 1976; Shaywitz et. al., 1979) and impairment in learning 
and memory (Abel, 1979; Lochry and Riley, 1980; Shaywitz et. al., 1979). Prenatal 
alcohol exposure also impairs maternal behavior in rats. Adult female rats that had been 
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exposed to alcohol prenatally, displayed poor nest building and pup-retrieving behaviors 
(Hard et al., 1985a). 
In addition, ethanol-exposed offspring exhibit abnormalities of neuroendocrine 
responses which are associated with hypothalamic neuronal activity. Adrenocortical 
responses to stressor or drug challenges were disturbed in rats exposed to ethanol in 
utero. These disturbances induced by in utero ethanol exposure were found in two 
opposite directions: the stress responses were decreased in both neonatal and prepubertal 
ages (Taylor et al., 1986; Weinberg, 1989), but the responses were increased in 
adulthood (Weinberg, 1988; Taylor et al., 1982). Male rats exposed to ethanol in utero 
had a feminized pattern of sexually dimorphic reproductive (Parker et al., 1984) and 
nonreproductive behaviors (McGivem et al., 1984). Fetuses and neonates exposed to 
ethanol in utero had a decreased testosterone surge (McGivern et al., 1988, 1993; Redei 
and McGivern, 1988). Since testosterone plays a role in the masculinization and 
defeminization of sexually dimorphic behavior and brain morphology (Dohler et al., 
1984, 1986), the reduced size of the sexually dimorphic nucleus of the preoptic area 
(SDN-POA) in male rats prenatally exposed to ethanol (Barron et al., 1988) may be the 
result of a decreased testosterone surge. 
In Utero Ethanol Effects on Brain Structures 
The evidence that in utero ethanol exposure results in abnormalities of learning 
and motor function suggests that ethanol-induced defects may be caused by abnormalities 
in the neocortex, hippocampus and cerebellum. Anatomical investigations have confirmed 
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this hypothesis. 
In prenatal ethanol-exposed rats, the total number of neurons and glia is 
decreased in the somatosensory cortex. These changes are accompanied by decreased 
neuronal and increased glial cell body size. The noted changes result in a decrease of 
overall volume of the somatosensory cortex (Miller and Potempa, 1990). The decreased 
number of neurons could be due to either a decrease in neuronal generation, or an 
increase in neuronal death, or both. In the cerebral cortex, neurons are generated 
between embryonic day (ED; day of insemination= EDO) 12 and ED 21. These neurons 
are generated by the proliferation of neuronal precursors particularly within the 
ventricular and subventricular zones (Angevine and Sidman, 1961). In ethanol-exposed 
rats generation of cortical neurons was decreased between ED12 and ED19, but after 
ED19 more neurons were generated (Miller, 1988). Decreased neurogenesis between 
ED12 to ED19 corresponds to the decreased cell proliferation in the ventricular zone, 
whereas increased neurogenesis after ED19 corresponds to the stimulated cell 
proliferation in the subventricular zone (Miller, 1989). Overall neuronal generation in the 
cortex of developing ethanol-exposed rats appears to be delayed. In contrast, specific 
neurons such as corticospinal neurons are increased in the ethanol-exposed rat offspring. 
This suggests that in utero ethanol exposure may also affect the process of axonal 
pruning (Miller, 1987). 
Disturbed neuronal migration has also been observed. Normally, neuronal 
migration occurs in an inside-to-outside pattern, which means that early-generated 
neurons reside in deep layers and late-generated neurons migrate along the earlier 
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neurons, and ultimately reside in the outer layer of cortex (Angevine and Sidman, 1961; 
Rakic, 1972). However, in ethanol-exposed rat offspring, late-generated neurons are 
found in the deep cortical layer (Miller, 1988). In addition, dendritic arborization of 
cortical pyramidal cells was stunted and less matured by in utero ethanol exposure 
(Hammer and Scheibe!, 1981; Schapiro et al., 1984; Stoltenburg-Didinger and Spohr, 
1983). 
A number of abnormalities have been found regarding hippocampal and dentate 
gyms neurons. Anatomical and electrophysiological vulnerability of the hippocampal 
formation to the neurotoxic effects of alcohol may contribute to the learning and 
cognitive deficits seen in FAS (Hoff, 1988). Although no change was observed in the 
number of hippocampal CA3 and dentate gyms (DG) granule cells, the neuronal 
connections between CA3 and DG were affected. Mossy fibers are the axons of granule 
cells of the dentate gyms innervating pyramidal cells of CA3. The mossy fibers were 
hypertrophied in rat offspring exposed to ethanol in utero (West et al., 1981). Prenatal 
alcohol exposure also delayed the appearance of complex synapses and multiple synaptic 
contacts on single neurons in dentate gyms (Hoff, 1988). In addition to these 
morphological disturbances, electrophysiological responses of the hippocampal neurons, 
such as long-term potentiation and potassium-induced excitability, were impaired 
(Swartzwelder, et. al., 1988). In contrast to the CA3 and DG regions, the number of 
pyramidal neurons in the hippocampal CAI region is decreased, and the dendritic 
morphology of these neurons is altered in rats exposed to ethanol prenatally (Barnes and 
Walker, 1981; Abel et al., 1983). Excitability of the neurons in the CAI region was 
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increased in rats exposed to ethanol in utero (Hablitz, 1986; Tan et. al., 1990). 
Behaviorally, these rats exhibit impaired passive avoidance learning (Tan et. al., 1990). 
In the cerebellum, Purkinje cells are generated prenatally and granule cells are 
generated postnatally. Ethanol exposure during the gestation period decreased the number 
of Purkinje cells, and delayed both the maturation of those cells and synaptogenesis in 
the molecular layer (Volk et al., 1981; Volk, 1984). Purkinje cell loss has been also 
shown in rats exposed to ethanol during the neonatal period, a time when these neurons 
are in the process of maturation. The influence of neonatal ethanol exposure on the 
degree of Purkinje cell loss in different regions correlates with the maturational state of 
the cells. The lobules I, IX, and X, in which Purkinje cells tend to mature early, were 
the most severely affected. In contrast, lobules VI and VII, in which Purkinje cells tend 
to mature late, were the least affected (Bonthius and West, 1990). In contrast to the 
hippocampus where no granule cell loss occurred, there is a loss of cerebellar granule 
cells in rats exposed to ethanol neonatally (Borges and Lewis, 1983; Bonthius and West, 
1990). 
Ethanol has been shown to affect neurogenesis, neuronal migration and/or 
neuronal cell death (Borges and Lewis, 1983; Bonthius and West, 1990). However, the 
effects of ethanol on the development of neurons appear to depend on the brain regions 
where the cells are located and the timing of ethanol exposure relative to the birth or 
development of the neurons. 
In Utero Ethanol Effects on the Development of Serotonergic System 
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Neurotransmitters and their receptors play an important role in neuronal activity. 
The effects of ethanol on the adult alcoholic brain have been studied in terms of the 
metabolism, turnover, storage and uptake of neurotransmitters, and receptor 
concentration (Rawat, 1974; Walsh et al., 1970; Kuriyama, et al., 1971). Similarly, the 
effects of in utero ethanol exposure on the levels of neurotransmitters, their metabolites 
and receptors have been studied in developing brains of animal models of FAS in order 
to elucidate the underlying causes of the CNS disorders associated with FAS. These 
studies have reported that development of many neurotransmitter systems are disturbed 
by in utero ethanol exposure (see Druse, 1992 for review). The serotonergic system, the 
most expansively distributed system throughout the brain (Tork, 1990), is one of the 
affected neurotransmitter systems. 
A number of studies suggested that the behavioral changes in FAS may be 
associated with altered serotonin activity. In utero ethanol-exposed mice and rats have 
shown hyperactivity, aggression, decreased sensory-motor responses and altered maternal 
behavior, all of which are signs of decreased 5-HT activity. In fact, the same animals 
have decreased brain serotonin content (Krsiak et al., 1977; Hard et al., 1985a, 1985b). 
Rat offspring exposed to ethanol prenatally have also been shown to have a significant 
decrease in the content of serotonin and its metabolites in its cell body region (the brain 
stem) and in its terminal regions, motor and somatosensory cortex at PN19 and PN35 
(Rathbun and Druse, 1985; Druse et al., 1991). One of the serotonergic terminal regions, 
motor cortex, also has decreased 5-HT uptake sites in prenatally ethanol-exposed rats 
(Druse and Paul, 1989). In addition, 5-HT1 receptors are decreased in the motor and 
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somatosensory cortex (Tajuddin and Druse, 1989). Cortical 5-HT2 receptors, however, 
are not affected by in utero ethanol exposure (Tajuddin and Druse, 1989a). 
Interestingly, the deficit of serotonin in the brain stem, cell body region, has been 
found as early as ED15. Since fetal serotonin plays an important role for the development 
and maturation of the serotonergic neuron and its target areas (Whitaker-Azmitia and 
Azmitia, 1986; Whitaker-Azmitia et al., 1987; Lauder and Krebs, 1978, 1984; Chubakov 
et al., 1986), the early deficiency of 5-HT may disturb the outgrowth of 5-HT fibers, and 
lead to abnormal CNS development seen in FAS. 
Effects of Ethanol on Astrocytes 
Astrocytes exert important roles in neuroembryogenesis by promoting neuritic 
growth over the astroglial surfaces and by providing trophic factors for the survival and 
functional maintenance of neurons (reviewed by Manthorpe et al., 1986). Abnormalities 
in the development of radial glial cells and astroglial cell dysfunction caused by ethanol 
treatment may contribute to the abnormal CNS development as in FAS. This may happen 
by disrupting neurite outgrowth and/or neuronal survival. Radial glial cells transform into 
astroglial cells after they serve as guides for migrating neurons (Schmechel and Rakic, 
1979). In utero ethanol exposure has been shown to induce premature degradation of 
radial glia, and accelerate the transformation of radial glia into astrocytes (Miller and 
Robertson, 1993). This may cause abnormal migration of cortical neurons seen in 
ethanol-exposed rats (Miller, 1988). Ethanol-exposed astrocytes exhibit abnormal 
morphology. They have a smoothened cell surface, less developed processes, decreased 
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content of glial fibrillary acidic protein (GFAP) and ultrastructural alterations (Babu et 
al., 1994; Davies and Cox, 1991; Mayordomo et al., 1992; Renau-Piqueras et al., 1989). 
In addition to the morphological changes, the activity of astroglial glutamine synthetase 
has been decreased by ethanol treatment (Babu et al., 1994; Davies and Vemadakis, 
1984). 5-HT uptake by astroglial cells was also decreased by ethanol exposure. The 
decrement of 5-HT uptake was due in part to decreased protein content in astroglial cells 
because 5-HT uptake was reduced to the same extent as astrocytic proteins (Lokhorst and 
Druse, 1993b). Astrocytes, cultured in the presence of ethanol, or astrocytes from 
ethanol-treated rats, cultured in the absence of ethanol have decreased protein content and 
decreased synthesis of DNA, RNA and protein (Babu et al., 1994; Davies and 
Vemadakis, 1984; Guerri et al., 1990; Snyder et al., 1992). Since astrocytes are known 
to synthesize and secrete neurotrophic factors which are essential for neuronal survival 
and growth, any alteration in the synthetic machinery may result in abnormal production 
of neurotrophic factors, which, in tum, can cause abnormal development of neurons. 
Possible Mechanisms 
Many clinical reports have demonstrated that ethanol can induce a wide range of 
detrimental effects on the developing fetus. Recently, many possible mechanisms by 
which in utero ethanol exposure adversely affects the development of CNS have been 
proposed. 
These effects of ethanol on the developing fetus could arise indirectly through 
the actions on the mother. For example, ethanol could affect maternal hormonal or 
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nutritional status, or altered placental function. The placental abnormalities can affect the 
developing fetus because it is totally dependent on the maternal oxygen and nutrient 
supply through placenta. Decreased placental transport of 14C-valine and placental-
facilitated diffusion of glucose have been observed. The latter has been correlated with 
intrauterine growth retardation (Henderson et al., 1981; Snyder et al., 1986). Since 
ethanol has been shown to decrease fetoplacental blood flow and cause umbilical artery 
spasm (Jones et al., 1981; Altura et al., 1983; Savoy-Moore et al., 1989), fetal hypoxia 
has been suggested as a mechanism by which in utero ethanol exposure causes the 
abnormal development of the brain (Michaelis, 1990). The regions of cell loss induced 
by in utero ethanol exposure include the CAl region of the hippocampus and cerebellar 
Purkinje cells (Barnes and Walker, 1981; Volk, 1984). Interestingly, cell loss in these 
regions is similar to those induced by hypoxia or ischemia (Jorgensen and Diemer, 1982; 
Auer et al., 1989). 
Ethanol is a lipophilic molecule which freely crosses the placental barrier 
(Waltman and Iniquez, 1972; Idanpaan-Heikkila, et al., 1972; Cook et al., 1975). In the 
human, the transfer of ethanol occurs within a minute and the alcohol concentration in 
the fetus can be as high as that in the mother (Idanpaan-Heikkila, et al., 1971; Waltman 
and Iniquez, 1972). In comparison with adults, fetuses have a relatively low activity of 
alcohol dehydrogenase, an ethanol-metabolizing enzyme (Pikkarainen, 1971). Thus, 
elimination of fetal alcohol depends on passive diffusion along the concentration gradient 
generated by effective maternal elimination of alcohol. Furthermore, it has been also 
reported that alcohol elimination from the amniotic fluid takes a much longer time than 
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from the maternal circulation (Brien et al., 1983). Thus, ethanol can be present for a 
longer period of time in the fetus than in the mother. Indeed, the direct effect of ethanol 
on fetal development has been shown in the chick embryo (Heaton et al., 1992). In 
addition, an investigation which cultured rat embryos in an ethanol-containing medium 
showed impaired development of the fetus in an ethanol concentration-dependent manner 
(Brown et al., 1979). 
Another possible mechanism by which ethanol can directly affect the fetal CNS 
may be through the alteration of either second messenger systems or the level of 
neurotransmitters. Neurotransmitters, such as serotonin, dopamine and norepinephrine, 
and second messengers, such as cyclic AMP, diacylglycerol, inositol phosphates and ca+2 
are important mediators of cell proliferation and differentiation (reviewed by Lauder, 
1993). In fact, ethanol-exposed fetuses and neonates had a decreased level of cyclic AMP 
and decreased cyclic AMP binding to the regulatory subunit of protein kinase A 
(Pennington, 1988). 3H-Forskolin binding sites (associated with cAMP) and [3H]-phorbol 
ester binding sites (associated with protein kinase C) were increased in the hippocampus 
and cortex of rat offspring exposed to ethanol in utero (Nio et al., 1991). 
Direct inhibition of protein synthesis in the fetal tissue by ethanol may also 
contribute to the damage associated with FAS. In utero ethanol administration has been 
shown to inhibit the synthesis of protein, RNA and DNA in fetal and neonatal brain 
tissue (Rawat, 1975; Sharma and Rawat, 1989). The neuronal cell loss in ethanol-
exposed rats may be due in part to decreased DNA synthesis (Michaelis, 1990). In 
addition, diminished neuronal growth and differentiation may be related to decreased 
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synthesis of proteins such as the astroglial growth factors (Dow and Riopelle, 1985; 
Heaton et al., 1992; Walker et al., 1990). 
In utero ethanol exposure may alter gene expression. Fetuses of the ethanol-
treated mice showed hypomethylation of DNA, and decreased nuclear methylase activity 
(Garro et al., 1991). Generally, hypermethylated regions of DNA are not transcribed, 
but hypomethylated regions are transcribed (Cedar, 1988). Thus, alterations of DNA 
methylation during embryogenesis can affect normal fetal gene expression, and thus fetal 
development. In vitro ethanol treatment has been shown to increase gene expression in 
neuronal cell lines. In NlE-115 neuroblastoma cells, ethanol increased tyrosine 
hydroxylase mRNA expression in a dose-dependent manner (Gayer et al., 1991). Ethanol 
also induced the gene transcription of the stress protein, Hsc70, and two related 
molecules, GRP94 and GRP78, in the NG 108-15 neuroblastoma x glioma cell line (Miles 
et al., 1991; Wilke et al., 1994). In the pheochromocytoma cell line (PC12) chronic 
ethanol exposure increased expression and function of dihydropyridine-sensitive calcium 
channels and enhanced neurite outgrowth induced by nerve growth factor (Roivainen et 
al., 1994). These effects of ethanol appear to be mediated through the activation of 
protein kinase C (Roivainen et al., 1994). Altered gene expression by prenatal ethanol 
exposure was also demonstrated in in vivo. Myelin basic protein mRNA levels (Kojima 
et al., 1994) and the mRNA for insulin-like growth factors I and II (Singh et al., 1994) 
were decreased in ethanol-exposed rat offspring. 
The Serotonergic Neurotransmitter System 
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Serotonin Receptors 
Fourteen serotonin receptor subtypes have been identified so far. It has been 
recently suggested that serotonin receptors could be classified according to the amino acid 
sequence homology, pharmacological properties, and transductional components 
(Humphrey et al., 1993). Thirteen serotonin receptor subtypes belong to the G protein-
linked superfamily and one belongs to the ligand-gated ion channel superfamily. Those 
which belong to the G protein superfamily can be divided into two subfamilies, the 5-HT1 
and 5-HT2 receptor families, based on the second messenger system with which they are 
coupled. The 5-HT1 receptor family is linked to the inhibition of adenylyl cyclase and 
includes 5-HT1A, 5-HTrn, 5-HT10, 5-HTrn, and 5-HTiF· The 5-HT2 receptor family is 
linked to the stimulation of phospholipase C and includes 5-HT2A, 5-HT28 , and 5-HT2c. 
The serotonin receptors linked to a ligand-gated ion channel are the 5-HT3 receptors. The 
other subtypes which are linked to G proteins are 5-HT4, 5-HT5A, 5-HT58 , 5-HT6, and 5-
HT7. Among these, three (5-HT4, 5-HT6 and 5-HT7) subtypes are linked to the stimulation 
of adenylyl cyclase. 
Binding affinity for spiperone was initially used to discriminate high affinity 5-
HT1A receptors from the low affinity 5-HTrn sites (Pedigo et al., 1981). Now, a more 
selective agonist, 8-hydroxy-2-(N,N-dipropylamino)tetralin (8-0H-DPAT), can be used 
to label the 5-HT1A receptor sites. The regional distribution of 5-HT1A receptors is similar 
in many species including rat, mouse, guinea pig, calf, cat, pig, monkey, and humans 
(Pazos and Palacios, 1985; Waeber et al., 1989; Kohler et al., 1986; Pazos et al., 1987). 
The highest density of 5-HT1A receptors are localized in limbic structures such as 
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hippocampus, septum, amygdala and entorhinal cortex. Astroglia cells in the septum and 
hippocampus of adult rats have been shown to express dense 5-HT1A receptors (Whitaker-
Azmitia et al., 1993). 5-HT1A receptors are present on the serotonergic cell bodies in 
dorsal and median raphe nuclei (Hall et al., 1985; Verge et al., 1985) where they serve 
as somatodendritic autoreceptors regulating 5-HT neuronal cell firing activity and thus 
serotonin release (Sprouse and Aghajanian, 1987). In the terminal region, for example, 
hippocampus and cortex, 5-HT1A receptors are located postsynaptically (Hall et al., 1985; 
Verge et al., 1986). These postsynaptic receptors are involved in the modulation of the 
release of other neurotransmitters. Stimulation of 5-HT1A receptors enhances acetylcholine 
release in the rat cortex (Sinniscalchi et al., 1990). In addition, postsynaptic 5-HT1A 
receptors are involved in the hypothalamo-hypophyseal axis. Stimulation of postsynaptic 
5-HT1A receptors results in the release of adrenocorticotrophin (ACTH), corticosterone, 
corticotrophin-releasing factor, prolactin and ~-endorphin (reviewed by Van de Kar, 
1991). 
5-HTrn sites have previously been identified by their low affinity for spiperone. 
Few drugs can bind to the 5-HTrn receptors with a nanomolar affinity. 5-HTrn sites are 
found only in some species such as rat and mouse brain in which they are densely 
localized in the substantia nigra and glob us pallidus (Pazos and Pallacios, 1985; Hoyer 
et al., 1985). 5-HTrn sites have been demonstrated to be presynaptic terminal 
autoreceptors in the frontal cortex, where they regulate the release of 5-HT (Middlemiss 
et al., 1988; Engel et al., 1986). These receptors are also located postsynaptically in the 
terminals of cholinergic fibers in the hippocampus, where they modulate the release of 
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acetylcholine (Maura and Raiteri, 1986). 
5-HT2A receptors are the classical 5-HT2 receptors. Initially PH]-spiperone was 
used to label the 5-HT2 sites. A high density of 5-HT2 receptor sites is found in the 
cortex. Low levels are present in the hippocampus, caudate, putamen and nucleus 
accumbens (Pazos et al., 1985; Biegon et al., 1986). 5-HT2 receptors are involved in the 
release of other neurotransmitters in a region-specific way. In the cortex and 
hippocampus activation of 5-HT2 receptors inhibits the K+ -evoked acetylcholine release 
(Muramatsu et al., 1988), whereas in the striatum 5-HT2 receptor agonists increase the 
basal release of acetylcholine and inhibit dopamine release (Bianchi et al., 1989; 
Muramatsu et al., 1988a). 
The receptors previously named as 5-HT1c have characteristics similar to the 5-
HT2 receptor family in terms of the nucleotide sequence homology, pharmacological 
profiles and second messenger system (Hoyer, 1988; Hartig et al., 1990). The 5-HT1c 
receptor has been renamed the 5-HT2c receptor. These receptors are highly localized in 
the choroid plexus and control the exchange between CNS and cerebrospinal fluid (Hartig 
et al., 1990). Low levels of 5-HT2c receptors are also present in the substantia nigra, 
globus pallidus, cortex and olfactory tubercles (Pazos et al., 1985a). 
5-HT3 receptors are ligand-gated ion channels, composed of four hydrophobic 
transmembrane regions (Maricq et al., 1991). 5-HT3 receptors are localized highly in the 
area postrema and some other areas such as cortex, amygdala, hippocampus, nucleus 
accumbens, thalamus and hypothalamus (Kilpatrick et al., 1987; Waeber et al, 1989a). 
Activation of 5-HT3 receptors facilitates the nonselective movement of monovalent 
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cations, resulting in the depolarization of cells (Yakel and Jackson, 1988; Neijt et al., 
1988). Activation of 5-HT3 receptors seems to stimulate the release of dopamine in the 
nucleus accumbens and amygdala (Hagan et al., 1990; Imperato and Angelucci, 1989). 
Roles of Serotonin in Various Regions 
5-HT and the Basal Ganglia 
The striatum and substantia nigra (SN) receive serotonergic projections mainly 
from the dorsal raphe (Dray et al., 1976; Fibiger and Miller, 1977; Palkovits, et al., 
1974; Steinbusch, 1981a). A majority of 5-HT terminals in the SN appear to be 
collaterals of the dorsal raphe-striatal projection (Van der Kooy and Hattori, 1980; Imai 
et al., 1986). In the striatum, dorsal raphe stimulation or local application of 5-HT 
suppresses spontaneous firing activity of most striatal neurons (Olpe and Koella, 1977). 
Selective destruction of 5-HT fibers entering the striatum decreased dopamine turnover 
and tyrosine hydroxylase activity within the striatum, suggesting that 5-HT terminals in 
the striatum facilitate dopamine transmission (Giambalvo and Snodgrass, 1978). These 
observations were extended by behavioral studies. Generally, animals tum towards the 
side where nigrostriatal neurons are less stimulated (Pycock, 1980). Striatal infusion of 
the serotonergic neurotoxin, 5,7-dihydroxytryptamine (5,7-DHT), facilitated turning 
behavior towards the ipsilateral side which implies that destruction of 5-HT terminals 
with 5, 7-DHT results in less stimulation of nigrostriatal dopamine neurons (Jacobs et al., 
1977). 
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In the SN, dorsal raphe stimulation inhibits the activity of most compacta cells 
and some reticulata cells (Fibiger and Miller, 1977). Serotonergic terminals in the SN 
synapse onto dopaminergic dendrites (Nedergaard et al., 1988). Microiontophoretic 
application of 5-HT increased dendritic calcium conductance of dopaminergic neurons 
in SN, which could result in dendritic dopamine release (Nedergaard et al., 1988; Trent 
and Tepper, 1991; Williams and Davies, 1983). Dopamine, released from dendrites 
following stimulation by 5-HT, may interact with somatodendritic D2 autoreceptors, and 
then cause decreased somatodendritic excitability of dopaminergic neurons (Groves et 
al., 1975; Bunney and Aghajanian, 1978). Behavioral effects caused by alterations of 5-
HT transmission in the SN have been studied. Local infusion of 5,7-DHT into the SN 
facilitated spontaneous locomotor activity (Carter and Pycock, 1979). Unilateral infusion 
of 5,7-DHT or p-chlorophenylalanine (pCPA) elicited turning behavior towards the 
contralateral side (Giambalvo and Snodgrass, 1978). Raphe nuclei lesions or pCPA 
treatment also facilitated amphetamine-induced locomotor hyperactivity (Costall et al., 
1979). It has been demonstrated that microinjection of the 5-HT uptake blocker, 
fluoxetine, into SN exerts an anticonvulsant action in the forebrain (Pasini et al., 1992). 
Behavioral studies, thus, suggest that 5-HT terminals in the SN play an important 
inhibitory role in controlling motor behavior. 
In the basal ganglia the actions of 5-HT appear to be modified by other 
neurotransmitters and 5-HT itself. Several neurotransmitters such as glutamate, GABA, 
substance P, acetylcholine, and dopamine have been shown to modify 5-HT release in 
the SN (Reisine et al., 1982; Soubrie et al., 1981; Hery et al., 1980). For example, SN 
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contains high levels of GABA, which is localized in nerve terminals of the striato- and 
pallido-nigral neurons (Di Chiara et al., 1980; Ribak et al., 1980). GABA tonically 
inhibits 5-HT transmission in the SN (Soubrie et al., 1981) through GABA receptors 
located on nigral 5-HT terminals (Gale, 1979). 5-HT itself released from dendrites in the 
raphe nuclei controls the terminal 5-HT release in the SN through the activation of the 
somatodendritic autoreceptors (Adell et al., 1993; Ferre and Artigas, 1993). 
5-HT and the Hippocampus 
Although the hippocampus receives fibers from both the median raphe and dorsal 
raphe, the median raphe is its major source of serotonergic innervation (Azmitia and 
Segal, 1978). 5-HT fibers from the median raphe project to the Comu Ammons (CA) 
areas and polymorphic layers of dentate gyrus (DG) where they innervate calbindin- and 
calretinin-containing GABAergic neurons (Freund et al., 1990; Acsady et al., 1993). 
Dorsal raphe neurons project to the molecular layer of DG where 5-HT fibers innervate 
dendrites of the granule cells (Azmitia and Segal, 1978). 
Either stimulation or application of 5-HT to the median raphe elicits long lasting 
inhibition of spontaneous activity of hippocampal pyramidal cells through an increase in 
potassium conductance (Segal, 1975, 1976; Beck and Choi, 1991). Lesioning of 
hippocampal serotonergic innervation results in hyperexcitability of granule cells in DG 
(Richter-Levin et al., 1994). 
The hippocampus appears to play an important role in the learning and memory 
process. The long-term potentiation (LTP) of synaptically evoked responses, believed to 
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be the cellular mechanism of learning and memory, has been described in a number of 
excitatory pathways in the hippocampus (Bliss, 1979; Milner, 1972). LTP can be 
recorded in the granule cells of DG and in the pyramidal cells of the CA3 by the 
electrical stimulation of the perforant path and mossy fibers, respectively. Studies with 
serotonergic fiber lesioning and raphe tissue grafts confirmed that serotonergic 
modulation of hippocampal activity is important in cognitive function. LTP in the DG 
was decreased in the rats treated with 5,7-DHT (Bliss et al., 1983). The activation of 5-
HT3 receptors seems to inhibit the induction of LTP in the CA3 (Maeda, et al., 1994). 
Lesioning of hippocampal serotonergic innervation results in impairment of spatial 
learning (Richter-Levin et al., 1994). There is a recovery of learning when rap he tissue 
is grafted into the hippocampus of animals which had combined serotonergic and 
cholinergic lesions (Richter-Levin et al., 1993). However, these results were not 
consistent. There is a report that serotonergic deafferentation of the hippocampus 
enhances spatial discrimination learning in rats (Altman et al., 1990). 
5-HT and the Amygdala 
The amygdala receives serotonergic inputs from both rostral and caudal raphe 
groups. Especially, the basolateral nucleus of the amygdala uniformly receives dense 5-
HT input from the dorsal raphe (Imai et al., 1986). Electrical stimulation or iontophoretic 
application of 5-HT on dorsal raphe inhibited the spontaneous firing of amygdaloid cells 
(Wang and Aghajanian, 1977). This inhibition was prevented in 5,7-DHT or pCPA 
treated rats. A marked decrease of 5-HT and 5-HIAA in pCPA-treated rats was 
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associated with increased sexual activity and aggressive behavior (Ferguson et al., 1970). 
Also, lesions of the amygdala showed alterations in sexual and aggressive behavior 
(Goddard, 1964). The inhibitory influence of dorsal raphe nucleus on amygdaloid cells, 
thus, has been connected with its important influence over sexual and aggressive 
behavior. 
5-HT and the Lateral Hypothalamus 
The lateral hypothalamic area contains medial forebrain bundle and the lateral 
hypothalamic nucleus (Sipe and Moore, 1977). The lateral hypothalamic nucleus (LHN) 
receives input from the brainstem reticular formation, medial hypothalamus, other lateral 
hypothalamus and basal forebrain (Millhouse, 1969; Nauta and Haymaker, 1969; 
Raisman, 1970). The neurons of LHN project into the adjacent medial hypothalamic 
zone. The LH is involved in the regulation of behaviors such as feeding (Baillie and 
Morrison, 1963; Teitelbaum and Epstein, 1962), locomotor activity (Balagura et al., 
1969; Gladfelter and Brobeck, 1962), sensorimotor integration (Marshall et al., 1971; 
Turner, 1973) and reward (Ols, 1973: Rolls, 1975). LH also contains serotonergic 
terminals (Moore, et al., 1978; Steinbusch, 198la; Heym and Gladfelter, 1982; Kai et 
al., 1988). 5-HT in LH plays an inhibitory role in food intake (Blundell, 1979; Coscina 
et al., 1972). 
5-HT and the Septum 
The septum is a part of the limbic system (Kohler et. al., 1982; Swanson and 
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Cowan, 1979) and is involved in the process of learning and memory, and 
neuroendocrine and autonomic regulation (De France, 1976). The septum can be divided 
into two parts, the lateral septa! and the medial septa! nuclei (Raisman, 1966; Chafetz 
et al., 1981). The lateral septum contains dense 5-HT terminals whereas the medial 
septum receives 5-HT fibers en route to other parts of the septum (Dinopoulos, et al., 
1993; Kohler et al., 1982). The lateral septum sends efferents to dorsal and medial raphe 
nuclei (Staiger and Nurnberger, 1991). Functionally, 5-HT in the lateral septum seems 
to play a role in memory consolidation. Direct infusion of the 5-HT uptake blocker, 
fluoxetine, into the lateral septum enhanced memory in rats (Lee et al., 1992). In the 
medial septum 5-HT appears to be involved in the regulation of neuronal discharge of 
both the medial septum and hippocampus. Some neurons in the medial septum discharge 
in an irregular manner which is synchronous with hippocampal theta spikes (Apostol and 
Creutzfeldt, 1974). Repetitive stimulation of the median raphe nucleus disrupts the 
bursting discharge of septa! neurons and hippocampal theta spikes (Assaf and Miller, 
1978). 
5-HT and the Frontal Cortex 
Serotonergic fibers innervate whole cortex, but the motor regions in the frontal 
lobe receive a lower extent than other cortical areas (Azmitia and Gannon, 1986). 
Laminar distribution of 5-HT fibers in monkeys shows that the highest densities are in 
layer I and IV (Azmitia and Gannon, 1986; Morrison et al., 1982). In adult rat brain, 
serotonergic fibers are localized in layer V whereas layer IV is densely innervated in the 
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developing brain (Blue and Molliver, 1985). 5-HT fibers projecting to cortex have been 
distinguished by the morphology and origin (Kosofsky and Molliver, 1987; Tork, 1990). 
One type is the thick fibers with large, spherical varicosities. These fibers arise from the 
median raphe nuclei and innervate equally to parietal, occipital and frontal cortex 
(O'Hearn and Molliver, 1984). Another type of 5-HT fibers is the thin fibers with small 
varicosities. These axons arise from the dorsal raphe nucleus and project heavily to 
frontal cortex (O'Hearn and Molliver, 1984). The exact functional role of dual 
serotonergic projections to the frontal cortex is unknown. However, serotonergic 
projections from the dorsal raphe nucleus to the frontal cortex could be involved with 
basal ganglia-motor system since frontal cortex is associated with motor function and DR 
nucleus also project to the caudate putamen (Steinbusch et al., 1980, 1981b). Additional 
studies suggest that the serotonergic system in the frontal cortex is associated with 
affective disorders and cognitive function (Stanley and Mann, 1983; Stanley et al., 1982; 
Bennett et al., 1979; Morris et al., 1993). 
Development of The Brain Serotonergic System 
Ontogeny 
5-HT containing neurons in the rat brain first appear at the ventricular zone along 
the border between the metencephalon and the rostral myelencephalon, and develop as 
bilateral superior and inferior cell groups (Lidov and Molliver, 1982; Wallace and 
Lauder, 1983; Aitken and Tork, 1988). Autoradiographic studies showed that 
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neurogenesis of 5-HT neurons in the superior cell groups occurs between EDll and 
ED 15 in the rat. 5-HT immunopositive cells in the superior cell group can be identified 
as early as ED12 (Lauder and Bloom, 1974; Levitt and Moore, 1978; Lidov and 
Molliver, 1982; Lauder et al., 1982; Aitken and Tork, 1988). The results of 
immunohistochemistry and [3H]-thymidine autoradiography studies indicate that 
serotonergic neurons synthesize their transmitter soon after they have completed their 
terminal mitosis (Lauder et al., 1982). 5-HT neurons in the superior cell group then 
differentially migrate during ED14 - ED19 to form subgroups of cells. These subgroups 
correspond to rostral raphe nuclei; dorsal raphe, median raphe, caudal linear raphe 
nuclei, and the B9 group in the adult rat brain. Midline fusion of bilateral superior cell 
groups starts at ED18. 
In contrast to the superior cell group, 5-HT immunoreactive cells in the inferior 
group are first detected at sites away from the ventricular zone around ED 14 in rat 
embryo (Lidov and Molliver, 1982). Thus, inferior 5-HT cells seem to complete much 
of their initial migration prior to the onset of phenotypic expression. These inferior cells 
give rise to the raphe magnus, raphe obscurus, and raphe pallidus and B3 group, found 
in the medulla of adult rat brain. Around the end of the embryonic period changes in the 
surrounding brainstem structures re-shape both the superior and inferior 5-HT cell groups 
to resemble that of adult 5-HT nuclei (Aiken and Tork, 1988; Lidov and Molliver, 
1982). In addition, most of these 5-HT neurons acquire more complex dendritic trees and 
undergo decreased cellular packing density. 
Nearly all ascending projections of the raphe nuclei are derived from the rostral 
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group of 5-HT neurons, whereas neurons in the caudal group give rise to the majority 
of descending fibers. Ascending projections seem to begin at ED13 and enter the basal 
forebrain as axons in the medial forebrain bundle (MFB) (Lidov and Molliver, l 982a; 
Lauder, 1990). According to the whole mount study of Aiken and Tork (1988), the 5-HT 
fibers contained within the MFB appear to be segregated into medial and lateral 
components which project to different regions of the forebrain. The medial part of the 
MFB contains fibers destined for the frontal pole of the telencephalon, whereas the lateral 
part contains fibers which project medially into the hypothalamus and cross in the 
supraoptic commissure. 5-HT axons reach the vicinity of all structures in the brain that 
are to receive a serotonergic innervation by ED19 and arrive at the cerebral cortex by 
the end of gestation. However, parieto-occipital areas of the cerebral cortex remain 
devoid of 5-HT fibers until the first postnatal week. The branching or arborization of 
axon terminals develop during the postnatal period. Initial development of ascending 5-
HT axons seems to follow a very circumscribed and directional growth. In all primary 
sensory areas of the cortex, dense patches of serotonergic innervation are seen in the rat 
brain from the neonatal period to postnatal day 21. This innervation pattern becomes 
more uniform in the adult rat neocortex (D' Amato, et al., 1987). By adulthood, 5-HT 
axons ramify extensively and innervate most of the brain (Steinbusch, 1981). 
Descending projections from the caudal raphe nuclei to the spinal cord course in 
the marginal zone along the ventricular and lateral funiculi and adult pattern of cord 
innervation seems to be achieved by postnatal day 21 (Rajaofetra et al., 1989). 
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5-HT Synthesis 
Although 5-HT-containing neuroblasts first appear as early as the twelfth day of 
gestation in the rat central nervous system, as shown using histofluorescence and 
immunohistochemistry (Olson and Seiger, 1972; Lauder et al., 1982; Lidov and 
Molliver, 1982), measurable amounts of 5-HT are first detected at ED15 (Liu et al., 
1987). This low concentration of 5-HT remains almost constant until the end of gestation. 
At birth, the concentration of whole brain 5-HT increases dramatically (Liu, et al., 1987; 
Herregodts, et al., 1990). However, its levels are still 25-50% of those in adult rats 
(Zeisel et al., 1981; Baker and Quay, 1969; Lauder and Bloom, 1974; Tissari, 1973). 
5-HT levels in the cell body and terminal regions show differences in the developmental 
profile. In the brain stem, the cell body region, 5-HT levels at birth are 32-75 % of those 
found in the same region of adult rats (Bourgoin et al., 1977; Nomura et al., 1976). The 
levels increase progressively till the end of the third postnatal week to a value slightly 
higher than those of adult rats. After that they level off to the adult level. In the 
forebrain, one of the terminal regions of 5-HT neurons, 5-HT levels at birth are about 
22 % of those in adult rat brain. 5-HT levels increase much more slowly in the forebrain 
region than in the brain stem, and are only 75 % of the adult levels at the end of the fifth 
postnatal week (Bourgoin et al., 1977). 
The developmental changes in 5-HT content seem to parallel the changes in the 
activity of tryptophan hydroxylase (TPH), the rate-limiting enzyme in the synthesis of 
5-HT (Schmidt and Sansers-Bush, 1971). Low levels of whole brain TPH activity have 
been detected at ED16 with in vitro assay (Renson, 1973) and ED15 with in vivo assay 
31 
(Liu et al., 1987). At birth, brain stem TPH activity is about 30-50% of that in adult rats 
(Deguchi and Barchas, 1972; Hamon and Bourgoin, 1982). The activity rapidly increases 
and reaches peak activity at the end of third postnatal week. It then decreases to adult 
levels (Park et al.,1986; Hamon and Bourgoin, 1982; Deguchi and Barchas, 1972). In 
the terminal regions, TPH activity is much lower than that in the cell body region, and 
reaches adult levels at around postnatal day 30 (Park et al., 1986; Hamon and Bourgoin, 
1982; Deguchi and Barchas, 1972). The apparent Km of the TPH in the newborn is about 
twice as high as in adult rats. The concentration of tryptophan, the substrate for TPH, 
is very high in the brain of newborn rat. For the first 2 days following birth, the brain 
tryptophan concentration is four to eight times higher than in adult rats (Zeisel et al., 
1981; Bourgoin et al., 1974). In the adult brain, the tryptophan concentration is between 
30 and 40 µM which is close to the Km value (50 µM) of TPH (Kaufman, 1974). The 
ratio of the tissue concentration of tryptophan to the apparent ~ of TPH is considered 
as an index of the saturation state of the enzyme (Bourgoin et al., 197 4). Although the 
affinity of TPH is low in neonate brain, the enzyme is in a highly saturated state 
compared to that of the adult because the concentration of the substrate is very high in 
the neonate brain. 
Such a high concentration of tryptophan is characteristic of the developing brain. 
The high tryptophan is due in part to the high activity of the tryptophan carrier in brains 
of newborn rats. In addition, the binding of circulating tryptophan to serum albumin is 
extremely low during the early postnatal period (Bourgoin et al., 1974). Therefore, free 
serum tryptophan is almost totally available for the tryptophan carrier. The increased 
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activity of the tryptophan carrier seems to be associated with an increased V max since the 
apparent affinity of the tryptophan uptake carrier is similar to that of adults (Hamon and 
Bourgoin, 1979). 
5-HT Metabolism 
5-HT is taken up by the serotonin transporter after it is released from the neuron. 
It is then degraded to 5-hydroxyindolacetic acid (5-HIAA) by monoamine oxidase 
(MAO). In vitro synaptosomal uptake of 5-HT increases rapidly in various brain regions 
for the first 2 weeks following birth (Kirksey and Slotkin, 1979). The Km values for 5-
HT reuptake are indistinguishable from adult values (Nomura et al., 1976). The 
increment in the 5-HT reuptake in the developing brain has been associated with an 
increase in the number of nerve endings or reuptake sites per ending (Kirksey and 
Slotkin, 1979) during the critical period of a developmental stage of the rat brain 
(Davison and Dobbing, 1968). 
The level of 5-HIAA is higher than that of 5-HT in the developing brain of rats. 
5-HIAA levels can be detected at ED17 and increase significantly around birth (Ribary 
et al., 1986). At birth, 5-HIAA levels are already as high as that of adults in the brain 
stem and about 50% of the adult value in the forebrain (Bourgoin et al., 1977). 5-HIAA 
levels increase progressively during the first three postnatal weeks in both the brain stem 
and the forebrain. Especially in the brain stem, the levels are significantly higher (85 % ) 
than adult values at the end of the third postnatal week (Bourgoin et al., 1977; Zeisel et 
al., 1981). Thereafter, the levels decrease to adult values by the sixth postnatal week. 
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The ratio of 5-HIAA/5-HT is very high during the fetal period and the first three 
postnatal weeks. During this period the ratio of 5-HIAA/5-HT remains two to four times 
higher than in adult rats (Herregodts et al., 1990; Bourgoin et al., 1977). In adult rats, 
the ratio of 5-HIAA/5-HT is dependent on the electrical activity of serotonergic neurons 
(Aghajanian et al., 1967). Similarly, the high value of the 5-HIAA/5-HT ratio in young 
brain may be the consequence of an enhanced rate of neuronal firing. However, the 
neurons of the dorsal raphe in neonate brain showed a regular discharge pattern, and the 
firing rate is not significantly different from that of the adult neurons (Lanfumey and 
Jacobs, 1982; Gallager, 1982). Alternatively the high turnover of 5-HT in the young 
brain may be due to either poor storage capacity of vesicles or enhanced enzymatic 
degradation. However, poor storage capacity may not play a role in the high turnover 
of 5-HT in newborn rat brain, since the conversion of PH]5-HT into [3H]5-HIAA is 
faster in the newborn than in adult rats even after reserpine treatment, which depletes 5-
HT storage capacity in tissues (Bourgoin et al., 1977). Rather, the high rate of enzymatic 
degradation of 5-HT seems to be the main cause of the high 5-HT turnover in developing 
rat brain. In fact, monoamine oxidase (MAO) activity peaks around birth. At ED15, total 
activity of MAO is composed of an equal proportion of MAO type A and type B (Liu 
et al., 1987). The activity of MAO A increases faster than that of type B. The high MAO 
A activity found in young rats seems to be associated with a high V max (Nelson et al., 
1979). The apparent affinity of MAO A for 5-HT does not change significantly 
throughout the development (Bourgoin et al., 1977). 
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Receptors 
In the human brain, 5-HT1A binding shows a prenatal peak (Bar-Peled et al., 1991) 
and decreases with age in the cortex, hippocampus and raphe nuclei (Dillon et al., 1991). 
However, in the rat brain, the levels of 5-HT1A receptors in the cortex, hippocampus and 
septum, are increased during the first three weeks after birth (Daval et al., 1987; Gozlan 
et al., 1990). In the cerebellum, high levels of 5-HT1A receptors are present at birth but 
disappear with age, suggesting that 5-HT1A receptors are involved in the regulation of the 
brain development (Daval et al., 1987; Hamon et al., 1990). Transcripts of 5-HT1A 
receptors are detected as early as ED 12 in the rat. The level of transcripts reaches its 
maximum concentration at ED 15 and decreases progressively to very low concentrations 
at ED20 (Hillion et al., 1993). Even though the level of 5-HT1A receptor mRNA at 
postnatal day (PN) 18 is higher than at ED18, its level is still markedly lower than at 
ED15. 
In the developing rat brain, 5-HT18 receptors appear in a vibrissa-related pattern 
in the primary somatosensory cortex. This pattern is no longer present in the adult brain 
(Leslie et al., 1992). The developmental profile of the 5-HT18 receptor is closely matched 
to that of 5-HT fiber immunoreactivity, which implies 5-HT18 receptors are expressed in 
the terminals of the developing 5-HT fibers (Leslie et al., 1992). The expression of 5-
HT18 receptor mRNA is detected at ED17 in whole brain (Voigt et al., 1991). The 
mRNA level is unchanged during development, whereas high levels of 5-HT18 receptor 
mRNA are expressed in the striatum, thalamus, and cerebellum at birth up to PN 12 and 
then remarkably decreases at adulthood (Voigt et al., 1991). 
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The 5-HT2 receptors are present prenatally in the rat cortex, hippocampus, 
caudate, pontine tegmentum (Morilak and Ciaranello, 1993). The expression of 5-HT2 
receptors in the developing brain parallels mRNA levels. 5-HT2 transcripts are detected 
as early as ED14 (Hellendall et al., 1993), and the expression of 5-HT2 receptor mRNA 
in whole brain increases 13-fold between ED 17 and PN 5 (Roth et al., 1991). The 
increase of the number of 5-HT2 receptors is about 8-fold between ED 17 and PN13 and 
then the number is reduced by 50% at PN 27 (Roth et al., 1991). These 5-HT2 receptors 
in immature brain are functionally active. 5-HT2 receptor-induced phosphatidyl inositide 
breakdown was greater in immature rat cortex than in adult (Claustre et al., 1988). 5-
HT1c receptor mRNA is also detected at ED14 (Hellendall et al., 1993). 5-HT1c receptor 
levels increased 2-fold between ED17 and PN13 and its mRNA levels increased 5-fold 
between PN2 and PN13 (Roth et al., 1991). 
Serotonin as a Developmental Signal 
In the developing brain, monoamine neurotransmitters appear early, especially one 
to several days before the generation of their target cells (Lauder and Bloom, 1974). 
These monoamines are believed to act as developmental signals in fetal brain before they 
act as neurotransmitters. Neurotransmitters seem to be released from the growing axon 
terminals into the surrounding environment (Hume et al, 1983; Young and Poo, 1983). 
They regulate neurite outgrowth of neighboring axons and the morphology of target cells 
during development (Handa et al., 1986; Lankford, 1987). 
The specific actions of serotonin as an extrinsic factor for the growth cone have 
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been demonstrated in cultures of identified neurons from the CNS of the snail helisoma. 
Application of serotonin to the culture medium inhibited growth cone motility, neurite 
elongation and electrical synaptic connections of identified snail buccal neurons (Haydon 
et al., 1987; McCobb et al., 1988). Altered 5-HT fiber growth was also observed in the 
snail nervous system by treating snail embryo with 5,7-DHT, which transiently lowers 
5-HT levels (Goldberg and Kater, 1989). 
Serotonin also regulates the growth of its own neurons (Whitaker-Azmitia and 
Azmitia, 1986). In co-cultures of fetal serotonergic neurons and target cells, low 
concentrations of 5-methoxytryptamine (5-MT) inhibited the growth of 5-HT neurons, 
whereas high concentration of 5-MT stimulated the growth of 5-HT neurons. These dual 
effects of serotonin on the growth of its own neurons were also demonstrated in whole 
animal studies, in which 5-HT terminal density was decreased with a low concentration 
of 5-MT treatment and increased with a high concentration of 5-MT (Shemer et al., 
1991). Serotonin has been shown to initiate and autoamplify its own synthesis in 
embryonic hypothalamic neurons (De Vitry et al., 1986). The autoregulatory function of 
5-HT is further demonstrated by the observation that Drosophila mutants, incapable of 
5-HT synthesis, exhibit altered branching of serotonergic axons (Budnik et al., 1989). 
The involvement of 5-HT in the target cell morpho-functional development was 
demonstrated in organotypic cultures. When 5-HT was added to cultured neurons from 
5-HT target tissues (e.g. cerebral cortex or hippocampus), it stimulated growth and 
differentiation of neurons, and enhanced synaptogenesis (Chumasov et al., 1980; 
Chubakov et al., 1986). The role of 5-HT in the target cell differentiation in vivo has 
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also been studied by manipulating the content of 5-HT in the embryonic brain. Maternal 
administration of pCPA, a 5-HT synthesis inhibitor, delayed neurogenesis of 5-HT target 
cells (Lauder and Krebs, 1978). 
These actions of 5-HT as a developmental signal seem to be mediated through 5-
HT receptors in the developing brain. 5-HT receptors are expressed in the fetal brain 
(Hillion et al., 1993; Hellendall et al., 1993; Morilak and Ciaranello, 1993; Roth et al., 
1991), and the number of 5-HT1 receptors was altered in the offspring treated with 
maternal pCPA or 5-MT (Whitaker-Azmitia et al., 1987). Also, stimulation of 5-HT1A 
receptors has been shown to modify neuritic branching of developing rat cortical neurons 
in vitro (Sikich et al. , 1990). 
The effect of serotonin on neuronal development can also be mediated through 
astroglia. Cultured astroglia possess a high affinity 5-HT uptake system (Katz and 
Kimelberg, 1985), serotonin binding proteins (Hertz and Tamir, 1981), the serotonin 
degrading enzyme, MAO (Fitzgerald et al., 1990), and 5-HT receptors (Fillion et al, 
1980, 1983; Whitaker-Azmitia and Azmitia, 1986a). Serotonin decreases the levels of 
GFAP and its mRNA in cultured astroglia derived from rat brainstem (Le Prince et al., 
1990). Application of a 5-HT1A receptor agonist shifted astroglial morphology to a more 
mature state (Whitaker-Azmitia et al., 1990). Stimulation of 5-HT1A receptors on 
cultured astroglial cells caused increased synthesis and release of a serotonergic growth 
factor, SlOOP (Whitaker-Azmitiaetal., 1990; Azmitiaetal., 1990). Theeffectof5-HT 
on the production of glial-derived trophic factors for dopaminergic neurons has also been 
demonstrated. The growth of dopaminergic neurons in the presence of mesencephalic glia 
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cells was stimulated by addition of 5-HT to the culture medium (Liu and Lauder, 1992), 
but no such effect was found in neurons cultured on the polylysine substrate (Liu and 
Lauder, 1991). 
The Effects of Buspirone on the CNS 
Buspirone is a non-benzodiazepine anxiolytic drug which has been used clinically 
for the treatment of anxiety (Feighner et al., 1982). Buspirone has little or no affinity 
for any of the major CNS receptors except dopamine D2 and 5-HT1A receptors. Binding 
of 3H-buspirone occurs in the regions rich in 5-HT1A receptors (Matheson and Tunnicliff, 
1991). Electrophysiological studies have shown that either systemic administration or 
iontophoretic application of buspirone produces a dose-dependent inhibition of the 
activities of serotonergic raphe neurons (VanderMaelen et al., 1986). Acute 
intraperitoneal administration of buspirone in rats reduces the synthesis of 5-HT in the 
brain (Hjorth and Carlsson, 1982). These effects of buspirone are due to the activation 
of 5-HT1A autoreceptors in the dorsal raphe. In addition, buspirone treatment results in 
increased plasma levels of corticosterone and reduced hippocampal rhythmical slow 
activity, both of which are mediated through the activation of the postsynaptic 5-HT1A 
receptors (Coop and McNaughton, 1991; Cowan et al., 1990). 
Buspirone also binds to dopamine D2 autoreceptors as an antagonist, and thus 
enhances dopaminergic neurotransmission (reviewed by Riblet et al., 1984). In the 
striatum where dopamine autoreceptors have been identified, buspirone increases tyrosine 
hydroxy lase activity and levels of dopamine metabolites (McMillen et al., 1983). 
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Although buspirone does not alter the activities of striatal choline acetyltransferase or 
acetylcholinesterase, buspirone reduces acetylcholine levels in the striatum (Kolasa et al., 
1982). Since dopamine inhibits the firing of acetylcholine neurons, the decreased level 
of acetylcholine induced by buspirone can be attributed to its antagonistic action on D2 
receptors. Buspirone has been shown to increase plasma prolactin levels (Metzer et al., 
1982; Urban et al., 1986), but this increase was only significant from postnatal day 12 
onward (Hocld et al., 1993). 
CHAPTER III 
METHODS 
In Vivo Studies 
Animals and Diet 
Virgin female Sprague-Dawley rats (Harlan) weighing 180 to 200 grams, were 
housed in individual cages and maintained at 23°C - 25°C and on a light/dark cycle 
(12/12 hour). The rats were allowed to adjust to the environment for 2 days before 
initiating liquid diets. 
On the first day of diet administration, all rats were given the control liquid diet. 
The caloric composition of the diet was 21 % protein, 29% fat, and 50% carbohydrate. 
The caloric concentration was 1 kcal/ml (Noronha and Druse, 1982). Water was given 
ad libitum. After 3 days of adjustment to the liquid diet, rats were divided into two 
weight-matched groups: i) ethanol-consuming dams; ii) pair-fed dams. The ethanol-fed 
rats were given liquid diet containing 6.6% (v/v) ethanol, while pair-fed rats received a 
volume of control liquid diet equal to the volume consumed by the ethanol-fed rats 
during the previous day. Ethanol accounts for approximately 35 % of the total calories 
in the ethanol diet, and replaces isocaloric amounts of carbohydrates (e.g. maltose-
dextrin) in the control diet. Diets were replenished daily. An ad libitum control group 
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which was fed with control diet ad libitum was included in experiments of specific aim 
1. The ethanol and control diets were pair-fed to rats for 5-6 weeks prior to breeding and 
during gestation. 
Female rats were mated. Breeding was confirmed by the detection of sperm in 
vaginal smears; that day was defined as embryonic day 0 (EDO). At parturition, rat 
mothers were given free access to chow plus either the control liquid diet (pair-fed 
controls) or half-strength (3.3% v/v) ethanol-liquid diet. On the third day after 
parturition, all rats were fed standard lab chow exclusively and litters were adjusted to 
9 pups. 
Drug Treatment 
Buspirone (RBI, Natick, MA) was administered from ED13 to ED20, when 5-HT 
neuronal differentiation and growth take place. Buspirone was dissolved in 0.9% sterile 
saline solution at a concentration of 3 mg/ml. After weighing, control- and ethanol-fed 
rats in drug treatment groups were given either a subcutaneous injection of saline or 
buspirone, at a dose of 4.5 mg/kg body weight. Injections were made once a day 
between 2 pm and 3 pm. Rats were monitored for a minimum of 30 minutes for any 
visible side effects. 
Blood Ethanol Level 
Blood ethanol levels were determined by using an enzymatic kit (Sigma St. Louis, 
MO). This kit measures ethanol by assessing the formation of reduced nicotinamide 
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adenine dinucleotide (NADH) in the oxidation-reduction reaction, in which ethanol plus 
nicotinamide adenine dinucleotide (NAD) are converted, respectively, to acetaldehyde 
and NADH. Alcohol dehydrogenase (ADH) catalyzes this reaction. The increase in 
absorbance at 340 nm occurs when NAD is converted to NADH, is directly proportional 
to the ethanol concentration in the sample. 
Blood samples were obtained from the tail vein two hours after the introduction 
of a fresh ration of diet to rats that had been fasted for 12 hours. Blood samples were 
collected in heparinized tubes (Becton Dickinson Inc., Lincoln Park, NJ) and 
deproteinized by the addition of trichloroacetic acid (6.25% w/v). Each tube was tightly 
capped and allowed to stand at room temperature for 5 minutes. The tube was then 
centrifuged at 2000 rpm for 5 minutes (Sorvall RT6000). One hundred microliters of 
supernatant were added to 2.9 ml of the NAD-ADH solution. The latter solution is 
prepared by adding 16 ml of glycine buffer to a multi-assay vial containing NAD-ADH. 
Mixed solutions were incubated for 10 minutes at room temperature. The solutions were 
transferred to cuvets, and the absorbance was measured at 340 nm (Gilford Response 
spectrophotometer). 
Dissection and Tissue Sectioning 
Rat offspring were sacrificed by decapitation on either postnatal day 5 (PN5), 
PN19 or PN35. The brains were quickly removed and frozen on dry ice. To obtain 
brains from ED19 rats, mothers were decapitated, and the uterine horn was removed and 
placed on an ice-cold glass plate. The brains from the fetuses were quickly removed and 
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frozen. Frozen brains were stored at -80 °C. Rats were sacrificed between 7 am and 9 
am. 
Twenty micron thick coronal sections of brains were cut at -18 °C using a cryostat 
(Leitz, Germany). Sections were thaw-mounted onto gelatin-coated microscope slides 
(Fisher, Pittsburg, PA). Four consecutive sections were put on one slide and every fifth 
section was set aside for staining with cresyl violet . These sections were put in an air-
tight slide box and stored at -8D°C until use. 
Staining of Tissue Sections 
Every fifth section was stained with a 0.5 % (w/v) cresyl violet (Sigma, St. Louis, 
MO) solution. These sections were compared with those in an atlas (Paxinos and Watson, 
1986) for identification of anatomical structures. In radioligand binding assays, brain 
sections from the same anatomical levels were selected. 
Tissue sections were warmed to room temperature and dehydrated by sequentially 
immersing the sections for 5 minute intervals in each of the following: xylene, xylene, 
100% (v/v) ethanol, 95% (v/v) ethanol, and 70% (v/v) ethanol. Slides were then dipped 
in distilled water and stained in the 0.5% (w/v) cresyl violet in acetate solution (0.06 M 
sodium acetate and 0.34 M glacial acetic acid, pH 3.9) for 25 minutes. Following 
staining, excess cresyl violet was removed by dipping the sections twice in distilled water 
for 3 minutes. Slides were then dehydrated by immersing them in 70% (v/v), 95% (v/v), 
and 100% (v/v) ethanol respectively. After dehydration, slides were put in xylene. A 
coverslip coated with Depex mounting medium (BDH Laboratory Suppliers, England) 
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was affixed to each slide. 
Labeling of 5-HT Recognition Sites 
5-HT Reuptake Sites 
Serotonin reuptake sites were measured according to the method of D 'Amato et 
al. (1987a). Slide-mounted tissue sections were brought to room temperature and 
preincubated for 15 minutes in 50 mM Tris buffer (pH 7.4) containing 120 mM NaCl, 
5 mM KCl and 0.001 % bovine serum albumin (BSA), in order to remove endogenous 
ligands. Tissue sections were then incubated for 60 minutes at room temperature in the 
incubation buffer containing 0.8 nM or 2.4 nM [3H] citalopram (NEN, Boston, MA). 
The K0 for [3H]citalopram is approximately 0.8 nM (D'Amato et al., 1987a). A 
concentration approximately three times the K0 concentration was used to estimate the 
binding at the Bmax. Non-specific binding was determined in the presence of 1 µM 
paroxetine (gift from Smith Kline Beecham Pharmaceuticals). Sections were then dipped 
(1-2 seconds) and washed twice for 10 minutes in ice-cold preincubation buffer, dipped 
in ice-cold distilled water for a few seconds, and dried in a cold air stream. Radiolabeled 
sections and a tritium-radiolabeled reference microscale were exposed to tritium sensitive 
Hyperfilm (Amersham, Arlington Heights, IL) at 4 °C for 4 weeks (for PN19 and PN35 
brain sections) or 60 days (for ED19 and PN5 brain sections). 
5-HT1A Receptor Sites 
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5-HT1A receptor sites were labeled with PH]8-hydroxy-2-(N,N-di-n-propylamino) 
tetralin ([3H]8-0H-DPAT; NEN) according to a modified protocol of Marlier et al. 
(1991). Slides were warmed to room temperature and preincubated in 170 mM Tris 
buffer (pH 7.6) containing 4 mM CaCl2 , 0.01 % ascorbic acid, and 0.001 % BSA. Tissue 
sections were then incubated for 60 minutes at room temperature in the incubation buffer 
containing 1 µM paroxetine, 10 µM pargyline, and 1.1 nM or 2. 75 nM [3H]8-0H-
DPAT. Non-specific binding was determined in the presence of 1 µM 5-HT. Paroxetine 
was included to prevent [3H]8-0H-DPAT binding to 5-HT reuptake sites. Pargyline was 
used to prevent degradation of 5-HT. Following incubation, sections were washed twice 
for 5 minutes in ice-cold preincubation buffer, dipped in ice-cold distilled water for 5 
seconds and dried in a cold air stream. Radiolabeled sections and [3H]-reference 
microscales were exposed at room temperature to tritium sensitive Hyperfilm for 4 weeks 
(for PN19 and PN35 brain sections) or 60 days (for ED19 and PN5 brain sections). 
Development of PH]-Exposed Film 
Autoradiograms were generated by developing the [3H] exposed film in the 
developing solution for X-ray film (Doehren Co., IL) for 40 seconds, washed in water 
for 20 seconds and fixed for 5 minutes at room temperature. Films were then rinsed in 
running water for 15 minutes and air-dried. 
Analyses of Autoradiograms 
The illuminated image of each autoradiogram was collected by a solid state 
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camera (Sony CCD Video Camera, Japan) and quantitated using a Macintosh-based 
image analysis system, NIH Image. The optical density of the reference microscale was 
interpolated to the radioactivity (DPM/mg protein) using tritium labeled brain mash 
standards. The optical density of tissue sections was converted to radioactivity based 
upon the calibration curve of the reference microscale. The radioactivity of tissue 
sections was then converted to pmol/mg protein depending on the specific activity of the 
radioligand. Brain structures on autoradiograms were identified in reference to the rat 
brain atlas (Paxinos and Watson, 1986). 5-HT reuptake sites were analyzed in the regions 
of raphe nuclei, lateral hypothalamus, substantia nigra, medial septal area, CA3 and 
frontal cortex. 5-HT1A receptor sites were examined in the raphe nuclei, amygdala, 
dentate gyros, CAl, lateral septal area and frontal cortex. 
In Vitro Cell Culture Studies 
Astroglial Cell Cultures 
Astroglial-conditioned media was obtained by the modified protocol of Rudge et 
al. (1985). Primary cultures of astroglial cells were prepared from the cerebral cortex of 
embryos from timed-pregnant Sprague-Dawley rats (Harlan) at 20 days of gestation 
(ED20; day of insemination = EDO). 
The uterine horn was aseptically removed from the body of a decapitated rat and 
placed into a sterile petri dish containing cold calcium- and magnesium-free Hank's 
balanced salt solution (CMF-HBSS; 5.4 mM KCl, 0.4 mM KH2P04, 4.2 mM NaHC03, 
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140 mM NaCl, 0.34 mM Na2HP04 , 5.6 mM glucose). The embryos were removed from 
the uterus and transferred twice to the other petri dishes containing fresh cold CMF-
HBSS. The brain was separated from the fetus; meninges were carefully removed under 
the dissecting microscope (Zeiss, Germany). Cerebral hemispheres were dissected and 
cleaned by removing the olfactory bulbs, striatum and hippocampal formation. Cortical 
tissues were cut into small pieces and collected in sterile CMF-HBSS. Minced cortical 
tissues were transferred to the CMF-HBSS containing 0.25% (w/v) trypsin/0.02% (w/v) 
EDTA (Sigma, St. Louis, MO) and 0.1 % (w/v) DNAse (Boehringer Mannheim, 
Indianapolis, IN), and incubated for 30 minutes at 37 °C. An equal volume of medium 
containing 10% fetal bovine serum (PBS; Gibco, Grand Island, NY) was added to 
inactivate trypsin. After centrifugation at 1000 g for 2 minutes, cells were resuspended 
and tritulated in a D-valine substituted Eagle's minimum essential medium (MEM), 
containing 10% FBS (heat-inactivated at 56°C for 1 hour) (MEM-FBS). D-Valine 
substituted MEM was used to inhibit the growth of fibroblasts. The media was modified 
to contain 26.4 mM NaHC03 (Sigma), 33.3 mM glucose (Sigma), 25 mM HEPES 
(Gibco), 25 µg/ml gentamicin (Gibco) and 0.25 µg/ml amphotericin (Gibco). Tritulated 
cells were filtered through a sterile 70 µ.m nylon mesh (Falcon, Lincoln Park, NJ). The 
number of viable cells was determined by trypan blue exclusion using a hemacytometer. 
Trypan blue excluding cells were placed in 162 cm2 flasks (Costar, Cambridge, MA) at 
the density of 7 x 1Q4 cells/cm2 (11.34 x 106 cells/flask). The cultures were maintained 
in a humidified atmosphere containing 5% C02. The culture medium was changed with 
fresh MEM-FBS on the day following seeding, and on every third day thereafter. After 
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2 weeks, astrocytes were subcultured. 
The day before subculture, 6-well plates (Costar, Cambridge, MA) were coated 
with poly-omithine (0.1 mg/ml in 1.15 M borate buffer) at room temperature. Two hours 
later, poly-omithine (PORN; Sigma) solution was aspirated and plates were washed three 
times with sterile water. Plates were then covered with 0.001 % fibronectin (FN; Sigma, 
St. Louis, MO.) and placed in a 37°C overnight. The plates were carefully washed three 
times with MEM and then covered with MEM until use (Plates should not be air-dried). 
On the day of subculture, astrocyte cultures were washed two times with warm 
CMF-HBSS and treated with 0.05% trypsin/ 0.02%EDTA/ 0.1 % DNAse solution for 15 
minutes. Trypsin action was stopped with MEM-FBS and the lifted cells were gently 
tritulated, pooled and centrifuged at 1000 g for 5 minutes. Cells were resuspended in 1 
ml of ovalbumin (1 % v/v)-containing MEM. After the number of viable cells were 
determined, the cell suspension was diluted with serum- and ovalbumin-free MEM to a 
density of 3 x 1()5 cells/ml. The density of 4.5 x 1()5 cells (1.5 ml) was added to each 
well, coated with PORN-FN. After 2 hours of incubation, media was changed to remove 
any residual ovalbumin and FBS. 
On the next day, the culture medium was changed and a portion of the cells were 
treated with ethanol (100 mM). Conditioned media from either control astroglia (CCM), 
or ethanol treated astroglia (ECM) were collected at the second and fourth day of ethanol 
treatment. CMs were centrifuged at 3500 rpm for 10 minutes and the supematants were 
preserved at -80 °C until use. 
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Neuronal Cell Cultures 
Primary neuronal cell cultures were generated from rhombencephalon of ED 14 
fetuses from timed pregnant Sprague-Dawley rats (Harlan). The same dissecting protocol 
used for the astroglial cultures was used for the rhombencephalic neuronal cultures. 
Rhombencephalon from between the rhombencephalic isthmus and the cervical flexure 
was dissected into small pieces in CMF-HBSS. The tissues were incubated with a 0.05% 
trypsin/EDTA/DNAse solution at 37 °C. After 30 minutes, an equal volume of 0.05% 
(w/v) soybean trypsin inhibitor was added to stop the trypsin action. The cells were 
centrifuged at 1000 g for 5 minutes. Precipitated cells were resuspended and tritulated 
in serum-free medium. Serum-free medium was made of Dulbecco's modified Eagle's 
medium and Ham's nutrient F-12 (DMEM/Fl2) containing 1 % penicillin-streptomycin 
(Sigma) and Bottenstein's N2 supplements (N2), 5 µglml insulin (Sigma), 100 µg/ml 
transferrin (Sigma), 20 nM progesterone (Sigma), 100 µM putrescine (Sigma) and 30 nM 
sodium selenite (Sigma). After the number of viable cells was determined, cells were 
seeded in the poly-D-lysine (33 µg/ml, Sigma) coated wells at a density of 8 x 1()4 
cells/cm2 (7.6 x 105 cells/well). Five hours later, 6 µM fluorodeoxyuridine (ICN, 
Cleveland, OH) and 12 µM uridine (Sigma) solution were added to inhibit proliferation 
of mitotic cells. 
On the day following seeding and on every other day thereafter, neuronal media 
was changed to either absolute N2 media or N2 media containing 30% CCM (30-CCM), 
60% CCM (60-CCM), 30% ECM (30-ECM), 60% ECM (60-ECM). On the fifth and 
sixth day of culture, neuronal cells were assayed. 
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Immunohistochemistry 
Pure astroglial cultures were identified by staining glial fibrillary acidic protein 
(GFAP), an astrocyte marker protein, using a peroxidase immunohistochemistry kit 
(Sigma). Astrocyte cultures were washed three times with warm phosphate-buffered 
saline (PBS: 2. 7 mM KCl, 1.5 mM KH2P04, 137 mM NaCl, 8 mM Na2HP04, 0.5 mM 
MgCl2, 0.9 mM CaCl2) and fixed with cold 4% paraformaldehyde for 1 hour. To block 
non-specific binding, cultures were incubated for 10 minutes with blocking reagent 
containing 1 % normal goat serum in PBS. After the blocking reagent was removed, 
cultures were incubated with primary anti-GFAP for 1 hour. Cultures were then washed 
three times with PBS and incubated with a biotinylated secondary antibody for 20 
minutes. After washing with PBS, cultures were incubated with peroxidase reagent for 
20 minutes, washed, and exposed to peroxidase substrate solution, containing chromogen, 
3-amino-9-ethylcarbazole (ABC) in N,N-dimethylformamide. 
Serotonin containing neurons were stained with anti-serotonin (lncstar, Stillwater, 
MN) using the peroxidase vectastain ABC kit (Vector Laboratory Inc., Burlingame, CA). 
Neuronal cultures were incubated with 100 µM L-tryptophan (Sigma) and 10 µM 
pargyline (Sigma) for 24 hours before staining. The staining procedures were the same 
as that for GFAP. For the 5-HT staining peroxidase substrate was composed of 0.03% 
H20 2 and 0.01 % diaminobenzidine (Sigma) in O. lM Tris buffer. 5-HT immunostained 
neuronal cultures were photographed using a Nikon inverted microscope at a 
magnification of 200x. The percentage of 5-HT immunopositive neurons was determined 
by counting the number of positively stained and unstained neurons. 
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Measurement of Neurite Length 
The neurite length was measured on the film negatives using the Macintosh based 
image analysis system, NIH Image. The longest neurite of each neuron was measured 
starting from the cell body to the end of neurite. 
5-HT Uptake 
5-HT uptake was determined by measuring the accumulation of [3H]5-HT by the 
neuronal cultures. Neuronal cultures were washed three times with warmed Hank's 
balanced salt solution (HBSS; 5.4 mM KCl, 0.4 mM KH2P04, 4.2 mM NaHC03 , 140 
mM NaCl, 0.34 mM Na2HP04 , 0.5 mM MgCl2, 1.26 mM CaCl2 , 0.41 mM MgS04 , 5.6 
mM glucose) and then incubated with 60 nM [3H]5-HT (Amersham) in HBSS containing 
0.1 mM L-cysteine (Sigma) for 20 minutes at 37 °C. Nonspecific uptake was determined 
using 10 µM fluoxetine (Lily, Indianapolis, IN). After incubation, the [3H]5-HT 
containing solution was removed and the cultures were washed three times with ice-cold 
HBSS. Cultures were then air-dried, and extracted with 1 ml of 95 % (v/v) ethanol for 
1 hour. At the end of extraction procedure, cells were scraped from the bottom and the 
wells were rinsed with 0.5 ml of 95 % ethanol. Two extracts were combined prior to 
tritium counting. An aliquot was saved for protein determination. 
Neuronal Number 
The number of surviving neurons was determined by counting with a 
hemacytometer. Neuronal cultures were rinsed with CMF-HBSS and incubated with 500 
52 
µl of 0.05% trypsin/EDTA/DNAse for 30 minutes at 37 °C. An equal volume of FBS-
MEM was added to stop the action of trypsin. Lifted cells were tritulated with 10 ml 
pipet and 9 inch Pasteur pipet. Dissociated cells were counted with hemacytometer. 
DNA Content 
DNA content was measured using a colorimetric assay developed by Burton 
(1956). Cultures were rinsed three times with HBSS. To each well of neuronal cultures 
was added 800 µl of 1 N NaOH. The bottom of each well was scraped after 30 minutes. 
Duplicate aliquots of 250 µl were transferred to test tubes. The remaining 300 µl was 
saved for protein determination. Standard DNA (Sigma), dissolved in 1 N NaOH was 
used at 10 different concentrations. Samples and standards were hydrolyzed for 30 
minutes at room temperature using 250 µ1of20% perchloric acid. During incubation, 
the acetaldehyde stock solution (16 mg/ml in distilled water) was diluted 1: 10. After the 
30 minute incubation, 500 µl of diphenylamine (40 mg/ml in glacial acetic acid) and 25 
µl of acetaldehyde (1.6 mg/ml) were added and the tubes were mixed. Test tubes were 
capped and shaken overnight in a 30 °C waterbath. The tubes were then centrifuged at 
800 g (Sorvall RT6000) for 10 minutes. The optical density of the samples and standards 
was read at 595 nm on a spectrophotometer (Gilford). 
Protein Determination 
Protein content was measured by a micromodification of the Lowry method 
(1951). Samples for protein measurement were previously collected from the same 
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cultures used for DNA measurements. Standards containing 0 and 25 µg protein were 
generated. Samples and standards were hydrolyzed in 100 µl of 1 N NaOH for 30 
minutes. During the incubation 1 % (w/v) cupric sulfate, 2 % (w/v) potassium-sodium 
tartrate and 2 % (w/v) sodium carbonate were mixed at a ratio of 0.1:0.1:10 (v/v/v) 
(solution A). To each sample and standard, 1 ml of solution A was added. The tubes 
were then vortexed. After 10 minutes 100 µl of Polin-phenol reagent was added and 
allowed to react for 30 minutes. The optical density of the standards and samples was 
read at 700 nm on a Gilford spectrophotometer. 
Statistical Analysis 
In the study of in utero ethanol effects on the development of 5-HT reuptake sites 
and 5-HT1A sites the results were analyzed using a two way analysis of variance 
(ANOVA) and a post-hoc Tukey's protected t test. The ANOVA with randomized block 
design was used. Each experiment was a block. In each experiment, samples from a 
given brain region from age-matched dietary groups were included. The results of cell 
culture studies were analyzed using a one way ANOVA followed by Tukey's protected 
t test. P values less than 0.05 were considered statistically significant. 
CHAPTER V 
RESULTS 
In Vivo Studies 
Maternal Weight Gain and Blood Alcohol Levels 
After 6 weeks of diet consumption, the average blood alcohol level (BAL) of 
ethanol-consuming rats was - 100 mg/dl; the BALs ranged from 75 to 120 mg/dl. 
Although the female rats consumed an increasing quantity of diet as pregnancy 
progressed, the amount of ethanol consumed (g/kg body weight) was constant because 
the maternal weight gains paralleled the increased diet consumption (Figure 1). During 
pregnancy (EDO to ED21) the maternal weight gain by pair-fed and ad lib controls (C-
PF, C-AD) and ethanol-fed rats (E-PF) was comparable (Table 1). The weights of 
offspring from these rats were also comparable. 
Effects of In Utero Ethanol Exposure on the Development of 
5-HT Reuptake Sites 
Since 5-HT reuptake sites are localized in nerve terminals, their concentration has 
been used as an index of serotonergic nerve fiber innervation of discrete brain areas. 5-
HT reuptake sites were radiolabeled with [3H]citalopram, a specific blocker of 5-HT 
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Fig. 1. Maternal weight gain and diet and ethanol consumption during pregnancy 
(EDO-ED21) in the ethanol-fed rats. The results are presented as the mean values 
obtained from five dams. The error bars represent SD. The asterisk denotes values which 
are significantly different from those of EDO (p<0.05). ED represents embryonic day. 
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TABLE 1 
EFFECTS OF IN UTERO ETHANOL EXPOSURE ON MATERNAL WEIGHT 
GAIN DURING PREGNANCY (EDl - ED21) AND ON OFFSPRING WEIGHTS 
Weight (g) 
C-PF (n) E-PF (n) C-AD (n) 
Maternal 115.7±18.1 (7) 108.6±20.5 (7) 153.0±47.3 (4) 
~ 
9.6±2.1 (6) 11.0±0.8 (8) 8.9±1.4 (4) 
Offspring 
PN19 
51.0±6.1 (8) 48.2±5.1 (8) 50.6±6.0 (3) 
All the data are presented as the mean ± SD. 
Abbreviations are as follows: C-PF, pair-fed control; E-PF, pair-fed ethanol; C-AD, ad 
libitum control; PN, postnatal day. 
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reuptake sites. Binding was done at 2 ligand concentrations. Binding at 0. 8 nM 
[3H]citalopram approximated the K0 , and that at 2.4 nM was used as an estimate of 
binding at the Bmax. Figure 2 depicts autoradiograms of brain regions from control rats, 
which were radiolabled with [3H]citalopram. Table 2 summarizes the specific binding of 
0.8 nM and 2.4 nM [3H]citalopram to brain regions from control rats, aged PN5 to 
PN35. In this table, the mean and standard deviation of all control values are provided. 
Data from the three groups of offspring are presented in Figures 3-10. These figures 
depict the binding in ethanol-exposed and ad lib offspring in comparison with that of age-
matched control offspring that were analyzed in the same experiment. Multiple (6 - 8) 
individual experiments were performed. Rather than pooling the values obtained from all 
experiments, each experiment was analyzed as a block. The results of a 2-way analysis 
of variance (ANOV A) using a randomized block design is summarized in the legends to 
the figures. 
On PN5, 5-HT reuptake sites could be quantitated in both the PCx and DR. 
However, binding was below the sensitivity of our method in other serotonergic brain 
areas at this age. By PN19, binding had increased in both the PCx and DR, as well as 
in the other brain regions listed in Table 2. At this age, the highest binding was found 
in the DR and MnR. The rank order of binding was DR - MnR > LH > SN > 
AMG > CA3 > PCx - FCx. With few exceptions the rank order of binding was 
similar at PN19 and PN35. Other than one data point (of a total of 18), the values for 
the specific binding of 0.8 nM and 2.4 nM [3H]citalopram to serotonergic brain regions 
was comparable in ad lib (C-AD) and pair-fed control rats (C-PF). 
Fig. 2. Autoradiographic images of serotonin reuptake sites in rat brain labeled with [3H)citalopram. 
Images of 20 µm thick coronal sections, labeled with 0.8 nM [3H]citalopram, are presented. A - D represent 
the level of forebrain (A-B), midbrain (C) and brainstem (D) of PN35 rats. E - F represent the level of forebrain 
(E) and brainstem (F) of PN5 rats. G represents a coronal section of brain stem from embryonic day 19 fetuses. 
H represents image of PN35 brain section showing nonspecific binding of [3H]citalopram in the presence of 
1 µM paroxetine. The color scale and corresponding radioactivity (DPM/mg protein) is shown on the right side. 
The warmer colors (red and yellow) correspond to higher densities and the cooler colors (blue and violet) 
correspond to lower densities. Abbreviations are as follows: FCX, frontal cortex; PCX, parietal cortex; MS, 
medial septum; STR, striatum; LH, lateral hypothalamus; BAL, basolateral nucleus of amygdala; CA3, 
hippocampus Comu Ammon 3; SN, substantia nigra; DR, dorsal raphe; MNR, median raphe. 
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TABLE2 
SPECIFIC BINDING OF [3H)-CITALOPRAM IN CONTROL PAIR-FED RA TS 
Specific binding (pmol/mg protein equivalent) 
0.8nM [3H]-citalopram 2.4nM [3H]-citalopram 
Region Age (n) (n) 
FCx PN19 0.286±0.094 (6) 0.507±0.197 (6) 
PN35 0.301±0.090 (6) 0.616±0.172 (6) 
PCx PN5 0.119±0.080 (6) 0.196±0.104 (6) 
PN19 0.343±0.120 (6) 0.530±0.152 (6) 
PN35 0.271±0.073 (6) 0.509±0.159 (6) 
CA3 PN19 0.541±0.301 (8) 0.910±0.268 (8) 
PN35 0.714±0.284 (8) 1.103±0.277 (8) 
LH PN19 1.249±0.313 (7) 1.671±0.335 (7) 
PN35 0.959±0.234 (7) 1.557±0.344 (7) 
AMG PN19 0.903±0.378 (8) 1.288±0.280 (8) 
PN35 1.128±0.291 (8) 1.698±0.245 (8) 
SN PN19 0.798±0.312 (6) 1.441±0.184 (7) 
PN35 1.105±0.312 (6) 1.53 7±0.395 (7) 
DR PN5 0.515±0.224 (6) 0.838±0.313 (6) 
PN19 1.713±0.160 (8) 2.098±0.174 (8) 
PN35 1.571±0.179 (8) 2.079±0.188 (8) 
MnR PN19 1.459±0.420 (7) 2.071±0.162 (7) 
PN35 1.129±0.194 (7) 1.803±0.193 (7) 
All the data are presented as the mean± SD. 
Abbreviation: FCx, frontal cortex; PCx, parietal cortex; CA3, hippocampus comu ammonis 
3; LH, lateral hypothalamus; AMG, amygdala; SN, substantia nigra; DR, dorsal raphe; MnR, 
median raphe; PN, postnatal day. 
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0 O.BnM CIT 2.4nM CIT O.BnM CIT 2.4nM CIT O.BnM CIT 2.4nM CIT 
PN5 PN19 PN35 
Fig. 3. Effects of in utero ethanol exposure on the binding of [3H)citalopram in the 
dorsal raphe. Results are expressed as percent of the specific binding obtained from the 
pair-fed control group at each age. The pair-fed control values are given in Table 2. The 
asterisk (*) denotes values which are significantly different from those in the age-matched 
pair-fed control group (F = 19.4, p = 0.0004), and the pound(#) denotes values which are 
significantly different from those in the age-matched ad libitum control group (F = 19.4, 
p = 0.0004). Abbreviations are as follows: C-PF, pair-fed control; E-PF, pair-fed ethanol; 
C-AD, ad libitum control; PN, postnatal day. 
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0.8nM CIT 2.4nM CIT 0.8nM CIT 2.4nM CIT 
PN19 PN35 
Fig. 4. Effects of in utero ethanol exposure on the binding of [3H]citalopram in the 
median raphe. Results are expressed as percent of the specific binding obtained from the 
pair-fed control group at each age. The pair-fed control values are given in Table 2. The 
asterisk (*) denotes values which are significantly different from those in the age-matched 
pair-fed control group (F = 7.7, p = 0.0071). Abbreviations are the same as those in Fig. 
3. 
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0.8nM CIT 2.4nM CIT 0.8nM CIT 2.4nM CIT 
PN19 PN35 
Fig. 5. Effects of in utero ethanol exposure on the binding of [3H)citalopram in the 
lateral hypothalamus. Results are expressed as percent of the specific binding obtained 
from the pair-fed control group at each age. The pair-fed control values are given in Table 
2. The asterisk (*) denotes values which are significantly different from those in the age-
matched pair-fed control group, and the pound(#) denotes values which are significantly 
different from those in the age-matched ad libitum control group (at PN19, 0.8 nM 
[3H]citalopram: F = 12.2, p = 0.0013; at PN19, 2.4 nM [3H]citalopram: F = 8.2, p = 
0.006; at PN35, 0.8 nM [3H]citalopram: F = 5.3, p = 0.02; at PN35, 2.4 nM 
[ 3H]citalopram: F = 12.1, p = 0.001). Abbreviations are the same as those in Fig. 3. 
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O.SnM CIT 2.4nM CIT 0.SnM CIT 2.4nM CIT 
PN19 PN35 
Fig. 6. Effects of in utero ethanol exposure on the binding of [3H]citalopram in the 
substantia nigra. Results are expressed as percent of the specific binding obtained from 
the pair-fed control group at each age. The pair-fed control values are given in Table 2. 
The asterisk (*) denotes values which are significantly different from those in the age-
matched pair-fed control group, and the pound(#) denotes values which are significantly 
different from those in the age-matched ad libitum control group (at PN19, 2.4 nM 
[3H]citalopram: F = 17.8, p = 0.0005; at PN35, 0.8 nM [3H]citalopram: F = 6.6, p = 0.01). 
Abbreviations are the same as those in Fig. 3. 
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0.8nM CIT 2.4nM CIT 0.8nM CIT 2.4nM CIT 
PN19 PN35 
Fig. 7. Effects of in utero ethanol exposure on the binding of [3H]citalopram in the 
basolateral nucleus of amygdala. Results are expressed as percent of the specific binding 
obtained from the pair-fed control group at each age. The pair-fed control values are 
given in Table 2. In utero ethanol exposure did not affect the binding of [3H]citalopram 
in this region at either age. Abbreviations are the same as those in Fig. 3. 
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0.8nM CIT 2.4nM CIT 0.8nM CIT 2.4nM CIT 
PN19 PN35 
Fig. 8. Effects of in utero ethanol exposure on the binding of [3H]citalopram in the 
hippocampal CA3. Results are expressed as percent of the specific binding obtained from 
the pair-fed control group at each age. The pair-fed control values are given in Table 2. 
In utero ethanol exposure did not affect the binding of [3H]citalopram in this region at 
either age. Abbreviations are the same as those in Fig. 3. 
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0 O.BnM CIT 2.4nM CIT O.BnM CIT 2.4nM CIT O.BnM CIT 2.4nM CIT 
PN5 PN19 PN35 
Fig. 9. Effects of in utero ethanol exposure on the binding of [3H]citalopram in the 
parietal cortex. Results are expressed as percent of the specific binding obtained from 
the pair-fed control group at each age. The pair-fed control values are given in Table 2. 
In utero ethanol exposure did not affect the binding of [3H]citalopram in this region at all 
ages. Abbreviations are the same as those in Fig. 3. 
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0.8nM CIT 2.4nM CIT 0.8nM CIT 2.4nM CIT 
PN19 PN35 
Fig. 10. Effects of in utero ethanol exposure on the binding of [3H]citalopram in the 
frontal cortex. Results are expressed as percent of the specific binding obtained from the 
pair-fed control group at each age. The pair-fed control values are given in Table 2. In 
utero ethanol exposure did not affect the binding of [3H]citalopram in this region at either 
age. Abbreviations are the same as those in Fig. 3. 
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Several significant abnormalities were found in the developing ethanol-exposed 
offspring. There was a transient increase in [3H]citalopram binding in the DR at PN5 
(Fig. 3), and in the MnR on PN35 (Fig. 4). There was also a decrease in binding in the 
LH at PN19 and PN35 (Fig. 5). In the SN (Fig. 6), binding was decreased at both PN19 
and PN35. In some cases, the significantly altered binding was detected at one but not 
both ligand concentrations. At the other ligand concentrations, a similar, though 
nonsignificant trend was noted. 
Effects of In Utero Ethanol Exposure on the Development of 
5-HT1A Receptors 
5-HT1A receptors were radiolabeled with either 1.1 nM or 2. 75 nM [3H]-8-0H-
DPAT, a specific 5-HT1A receptor agonist. Figure 11 depicts autoradiograms of control 
brain regions from rats aged PN5 and PN35. Table 3 contains the values for the mean 
and standard deviations for the specific binding of [3H]-8-0H-DPAT to brain regions 
from control rats. In each binding assay, samples from C-PF, C-AD, and E-PF rats were 
included. The radiolabeled sections from a given experiment were exposed to a single 
film. The results of the multiple experiments were compared using the randomized block 
design, in order to adjust for differences between individual experiments. Figures 12 -
17 depict the values for C-AD and E-PF rats as a percentage of the values for C-PF rats, 
included in the same experiment. Statistical differences were calculated using a 2-way 
ANOV A with random block design. 
At PN5, binding of [3H]-8-0H-DPAT was detectable only in the DG. However, 
Fig. 11. Autoradiographic images of 5-HT1A receptor sites labeled with [3H]-8-0H-DPAT. Images of 
20 µm thick coronal sections, labeled with 1.1 nM [3H]-8-0H-DPAT, are presented. A - C represents 
sections of forebrain (A and B) and brainstem (C) of PN35 rats. D represents the section of forebrain of 
PN5 . Nonspecific binding of [3H]-8-0H-DPAT in the presence of 1 µM 5-HT is shown in E. The color scale 
and corresponding radioactivity are shown in F. The warmer colors (red and yellow) correspond to higher 
densities and the cooler colors (blue and violet) correspond to lower densities. Abbreviations are as follows : 




SPECIFIC BINDING OF [3H]-8-0H-DPAT IN CONTROL PAIR-FED RA TS 
Specific binding (pmol/mg protein equivalent) 
1.lnM [3H]-8-0H-DPAT 2.75nM [3H]-8-0H-DPAT 
Region Age (n) (n) 
FCx PN19 0.099±0.033 (7) 0.164±0.076 (6) 
PN35 0.166±0.042 (7) 0.242±0.069 (6) 
PCx PN19 0.154±0.070 (7) 0.226±0.071 (7) 
PN35 0.212±0.057 (7) 0.279±0.084 (7) 
LS PN19 0.580±0.168 (6) 0.709±0.180 (6) 
PN35 0 .5 3 5±0. 066 (6) 0.658±0.119 (6) 
DG PN5 0.232±0.071 (6) 0.265±0.089 (6) 
PN19 0.584±0.132 (6) 0.737±0.185 (6) 
PN35 0. 731±0.073 (6) 0.825±0.191 (6) 
DR PN19 0.575±0.142 (6) 0.685±0.191 (6) 
PN35 0.581±0.140 (6) 0.646±0.100 (6) 
MnR PN19 0.270±0.080 (6) 0.354±0.115 (6) 
PN35 0.150±0.040 (6) 0.245±0.082 (6) 
All the data are presented as the mean± SD. 
Abbreviation: FCx, frontal cortex; PCx, parietal cortex; LS, lateral septum; DG, dendate 
gyrus; DR, dorsal raphe; MnR, median raphe; PN, postnatal day. 
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Fig. 12. Effects of in utero ethanol exposure on the binding of [3H]-8-0H-DPAT in 
the dentate gyrus. Results are expressed as percent of the specific binding obtained from 
the pair-fed control group at each age. The pair-fed control values are given in Table 3. 
The asterisk (*) denotes values which are significantly different from those in the age-
matched pair-fed control group (F = 3.8, p = 0.058), and the pound (#) denotes values 
which are significantly different from those in the age-matched ad lib control group (F 






















CJ C-PF - E-PF 11111 C-AD 
1.1nM DPAT 2.75nM DPAT 
PN19 
1.1nM DPAT 2.75nM DPAT 
PN35 
Fig. 13. Effects of in utero ethanol exposure on the binding of [3H]-8-0H-DPAT in 
the parietal cortex. Results are expressed as percent of the specific binding obtained 
from the pair-fed control group at each age. The pair-fed control values are given in Table 
3. The asterisk (*) denotes values which are significantly different from those in the age-
matched pair-fed control group (at PN35, 1.0 nM [3H]-8-0H-DPAT: F = 4.2, p = 0.04; 
at PN35, 2.7 nM [3H]-8-0H-DPAT: F = 4.3, p = 0.04). Abbreviations are the same as 
those in Fig. 3. 
72 

















1.1nM DPAT 2.75nM DPAT 1.1nM DPAT 2.75nM DPAT 
PN19 PN35 
Fig. 14. Effects of in utero ethanol exposure on the binding of [3H]-8-0H-DP AT in 
the frontal cortex. Results are expressed as percent of the specific binding obtained from 
the pair-fed control group at each age. The pair-fed control values are given in Table 3. 
In utero ethanol exposure did not affect the binding of [3H]-8-0H-DP AT in this region 























c::::J C-PF - E-PF Ill C-AD 
1.1nM DPAT 2.75nM DPAT 
PN19 
1.1nM DPAT 2.75nM DPAT 
PN35 
Fig. 15. Effects of in utero ethanol exposure on the binding of [3H]-8-0H-DPAT in 
the lateral septum. Results are expressed as percent of the specific binding obtained from 
the pair-fed control group at each age. The pair-fed control values are given in Table 3. 
In utero ethanol exposure did not affect the binding of [3H]-8-0H-DPAT in this region 



















c::::J C-PF - E-PF 1111!1 C-AD 
1.1nM DPAT 2.75nM DPAT 
PN19 
1.1nM DPAT 2.75nM DPAT 
PN35 
Fig. 16. Effects of in utero ethanol exposure on the binding of [3H]-8-0H-DPAT in 
the dorsal raphe. Results are expressed as percent of the specific binding obtained from 
the pair-fed control group at each age. The pair-fed control values are given in Table 3. 
Jn utero ethanol exposure did not affect the binding of [3H]-8-0H-DPAT in this region 
at either age. Abbreviations are the same as those in Fig. 3. 
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1.1nM DPAT 2.75nM DPAT 1.1nM DPAT 2.75nM DPAT 
PN19 PN35 
Fig. 17. Effects of in utero ethanol exposure on the binding of [3H]-8-0H-DPAT in 
the median rap he. Results are expressed as percent of the specific binding obtained from 
the pair-fed control group at each age. The pair-fed control values are given in Table 3. 
In utero ethanol exposure did not affect the binding of [3H]-8-0H-DPAT in this region 
at either age. Abbreviations are the same as those in Fig. 3. 
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by PN19 5-HT1A receptors could be quantitated in several brain areas. At both PN19 and 
PN35 binding was highest in the DR, DG and LS. Somewhat lower binding was noted 
in the MnR, PCx and FCx. With one exception, there were no significant differences in 
the binding of PH]-8-0H-DPAT to tissue from pair-fed and ad lib control offspring. 
However, in ethanol-exposed offspring there was a transient increase in PH]-8-0H-DPAT 
binding in the DG (PN19, Fig. 12) and a transient decrease in binding in the PCx (PN35, 
Fig. 13). 
Effects of Buspirone Treatment on the 
Ethanol-Associated Developmental Abnormalities in 
5-HT Reuptake Sites and 5-HT1A Receptors 
Previous investigations from this laboratory (Druse et al., 1991) indicated that 5-
HT content was decreased by -50% in the brain stem of ED15 rats. Since fetal 5-HT 
appears to function as an essential trophic factor for the development of serotonergic as 
well as other types of neurons, it was hypothesized that the ethanol-induced fetal deficit 
of 5-HT could contribute to the subsequent abnormal development of serotonergic 
neurons by decreasing stimulation of 5-HT1A receptors. In order to test this hypothesis, 
pregnant control and ethanol-fed dams were treated with buspirone, a 5-HT1A agonist, 
from ED13 to ED20 to determine whether treatment with a 5-HT1A agonist could prevent 
or reverse ethanol-associated developmental abnormalities. Additional control and 
ethanol-fed dams were treated with saline instead of buspirone. The offspring of these 
dams were used for analysis of 5-HT reuptake and 5-HT1A receptors. All rats used in 
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these studies were distinct from those described in sections 2 and 3. Nonetheless, a 
portion of these studies replicated the work reported in those sections. In addition, it 
expanded the earlier studies to include additional brain regions and/or ages, and 
strengthened the observations by including a large sample number. 
Following subcutaneous injection of buspirone, the pregnant rats sometimes 
exhibited brief and mild symptoms of the serotonin syndrome (Smith and Peroutka, 
1986). These rats exhibited a flattened body posture and outstretched forepaws. In 
addition, the buspirone-treated control (CB) dams exhibited a smaller weight gain than 
that noted in either of the pair-fed groups (Table 4). In contrast, the weight gain in both 
of the ethanol-treated groups (ethanol-saline, ES; ethanol-buspirone, EB) was comparable 
to that of the control-saline (CS) group. Despite the noted effects on the dams, the weight 
gain in the offspring of buspirone-treated control- and ethanol-fed rats was not 
significantly different at PN5, PN19 and PN35 (Fig. 18). 
Table 5 contains the values for the specific binding of 0.8 nM and 2.4 nM 
[3H]citalopram to brain sections obtained from the offspring of saline-treated, pair-fed 
control rats (CS). Specific binding was readily detected in the DR by ED19 and in the 
PCx by PN5. On PN19 and PN35 the highest binding was found in the DR and MnR. 
The rank order of binding was DR > MnR > LH - SN - AMG > MS - CA3 > 
Striatum - PCx - FCx. This pattern was generally similar to that noted in the earlier 
experiment (Table 2). 
When [3H]citalopram binding was compared in the offspring of pair-fed control 
and ethanol dams, we noted that the ethanol-exposed offspring had a significant decrease 
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in binding in several regions. Binding was decreased at one or both ligand concentrations 
in the FCx (PN19, Fig. 19), PCx (PN19, Fig. 20), LH (PN19 & PN35 Fig. 21), SN 
(PN19 & PN35, Fig. 22), MS (PN19, Fig. 23) and striatum (PN19 & PN35, Fig.24). 
In contrast, binding was increased in the DR (Fig. 25) on PN5 and MnR (Fig. 26) on 
PN19 and PN35. The noted observations in the DR, LH and SN confirm earlier findings; 
those in the MS and ST expand the first study which did not examine the latter brain 
areas. It should also be noted that in both investigations, we did not detect any ethanol-
associated changes in the hippocampus (CA3, Fig. 27) or amygdala (Fig.28). A few 
significant differences were noted in one, but not both studies. For example, the latter 
study detected significantly decreased [3H]citalopram binding in the frontal and parietal 
cortex. A similar, though nonsignificant trend was found in the frontal cortex in the first 
investigation. 
When the PH]citalopram binding was compared in the offspring of saline- and 
buspirone treated dams, maternal treatment with buspirone prevented or reversed some 
of the ethanol-associated developmental abnormalities in 5-HT reuptake sites. Buspirone 
prevented the decline in binding of PH]citalopram at either the low or high concentration 
noted in the FCx (PN19, Fig. 19), LH (PN19 & PN35, Fig. 21), SN (PN35, Fig. 22), 
and MS (PN19, Fig. 23). Similarly, buspirone treatment reversed the ethanol-associated 
increase in binding in the DR (PN5, Fig. 25) and MnR (PN19, Fig 26). In contrast, 
maternal buspirone treatment had no effect on the decreased number of reuptake sites in 
the PCx (Fig. 20) and Striatum (Fig. 24). Buspirone treatment alone had little effect on 
[3H]citalopram binding to reuptake sites. 
TABLE4 
WEIGHT INCREASE DURING PREGNANCY 
(From EDl to ED20) 
n Weight increase (g) 
cs 5 136.0±13.4a 
CB 5 110.4±14.3* 
ES 5 124.8±14.3 
EB 5 118.4±11.7 
aData are presented as the mean± SD. 
*p<0.05 compared to CS. 
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PN 5 PN 19 PN 35 
Fig. 18. Effect of buspirone treatment on the weight of offspring at PN5, PN19 and 
PN35. The results are presented as the mean values obtained from pups of eight different 
dams. The error bars represent SD. Abbreviations are as follows: CS, saline treated pair-
fed control; CB, buspirone-treated pair-fed control; ES, saline-treated ethanol-fed; EB, 
buspirone-treated ethanol-fed; PN, postnatal day. 
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TABLES 
SPECIFIC BINDING OF [3H]-CITALOPRAM IN THE CONTROL SALINE GROUP 
Specific binding (pmol/mg protein equivalent) 
0.8nM [3H]-citalopram 2.4nM [3H]-citalopram 
Region Age (n) (n) 
FCx PN19 0.194±0.116 (7) 0.509±0.180 (6) 
PN35 0.243±0.141 (7) 0.719±0.208 (6) 
PCx PN5 0.278±0.147 (5) 0.334±0.223 (8) 
PN19 0.325±0.172 (6) 0.607±0.260 (6) 
PN35 0.290±0.151 (6) 0.687±0.159 (6) 
MS PN19 0.619±0.245 (7) 1.045±0.306 (7) 
PN35 0.570±0.304 (7) 1.103±0.286 (7) 
Striatum PN19 0.322±0.155 (7) 0.701±0.173 (7) 
PN35 0.343±0.170 (7) 0.713±0.208 (7) 
CA3 PN19 0.441±0.219 (8) 0.922±0.265 (8) 
PN35 0.534±0.277 (8) 0.981±0.242 (8) 
LH PN19 1.091±0.397 (7) 1.919±0.397 (7) 
PN35 0.975±0.264 (7) 1.658±0.327 (7) 
AMG PN19 0.781±0.303 (7) 1.298±0.489 (7) 
PN35 1.013±0.322 (7) 1.626±0.425 (7) 
SN PN19 1.129±0.309 (7) 1.629±0.474 (7) 
PN35 1.071±0.227 (7) 1.710±0.278 (7) 
DR ED19 0.386±0.207 (6) 0.471±0.282 (6) 
PN5 0.330±0.109 (5) 0.320±0.188 (7) 
PN19 1.769±0.209 (7) 2.547±0.582 (7) 
PN35 1.757±0.214 (7) 2.485±0.308 (7) 
MnR PN19 1.592±0.234 (6) 2.400±0.405 (7) 
PN35 1.343±0.263 (6) 1.910±0.315 (7) 
All the data are presented as the mean± SD. 
Abbreviations are same as in Table 2 except MS, medial septum. 
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C:=J CS ~ CB - ES ~ EB 
0.8nM CIT 2.4nMCIT 0.8nM CIT 2.4nMCIT 
PN 19 PN 35 
Fig. 19. Effects of buspirone treatment on the binding of [3H]citalopram in the 
frontal cortex. Results are expressed as percent of the specific binding obtained from the 
control saline group at each age. The control saline values are given in Table 5. Statistical 
analysis was performed on the specific binding values. The asterisk (*) denotes values 
which are significantly different from those in the age-matched control saline group. 
Abbreviations are as follows: CS, control saline; CB, control buspirone; ES, ethanol 




















c::::::::J CS fWAJ CB - ES ~ EB 
0 O.BnM CIT 2.4nM CIT O.BnM CIT 2.4nM CIT O.BnM CIT 2.4nM CIT 
PN5 PN19 PN35 
Fig. 20. Effects of buspirone treatment on the binding of [3H]citalopram in the 
parietal cortex. Results are expressed as percent of the specific binding obtained from 
the control saline group at each age. The control saline values are given in Table 5. 
Statistical analysis was performed on the specific binding values. The asterisk (*) denotes 
values which are significantly different from those in the age-matched control saline 
group (PN19, 0.8 nM [3H]citalopram: F = 8.7, p = 0.03). Abbreviations are the same as 
those in the Fig. 19. 
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0.8nM CIT 2.4nM CIT 0.8nM CIT 2.4nM CIT 
PN 19 PN 35 
Fig. 21. Effects of buspirone treatment on the binding of [3H]citalopram in the 
lateral hypothalamus. Results are expressed as percent of the specific binding obtained 
from the control saline group at each age. The control saline values are given in Table 
5. Statistical analysis was performed on the specific binding values. The asterisk (*) 
denotes values which are significantly different from those in the age-matched control 
saline group (PN19, 0.8 nM [3H]citalopram: F = 13.7, p = 0.01; PN19, 2.4 nM 
[3H]citalopram: F = 7.4, p = 0.03). The pound(#) denotes values which are significantly 
different from those in the age-matched ethanol saline group (PN35, 0.8 nM 
[ 3H]citalopram: F = 12.5, p = 0.01). There was also a significant ethanol x buspirone 
interaction at PN19, 0.8 nM [3H]citalopram (F = 10.0, p = 0.02) and at PN35, 0.8 nM 



















c::::::::J CS rAd CB - ES ~ EB 
0.8nM CIT 2.4nM CIT 0.8nM CIT 2.4nM CIT 
PN 19 PN 35 
Fig. 22. Effects of buspirone treatment on the binding of [3H]citalopram in the 
substantia nigra. Results are expressed as percent of the specific binding obtained from 
the control saline group at each age. The control saline values are given in Table 5. 
Statistical analysis was performed on the specific binding values. The asterisk (*) denotes 
values which are significantly different from those in the age-matched control saline 
group (PN19, 0.8 nM [3H]citalopram: F = 27.0, p = 0.002; PN19, 2.4 nM [3H]citalopram: 
F = 12.1, p = 0.01). The dollar sign($) denotes values which are significantly different 
from those in the age-matched control buspirone group (PN19, 0.8 nM [3H]citalopram: 
F = 27.0, p = 0.002; PN19, 2.4 nM [3H]citalopram: F = 12.1, p = 0.01). Abbreviations 
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~CS r. CB - ES ~ EB 
0.8nM CIT 2.4nMCIT 0.8nM CIT 2.4nM CIT 
PN 19 PN 35 
Fig. 23. Effects of buspirone treatment on the binding of [3H]citalopram in the 
medial septum. Results are expressed as percent of the specific binding obtained from 
the control saline group at each age. The control saline values are given in Table 5. 
Statistical analysis was performed on the specific binding values. The asterisk (*) denotes 
values which are significantly different from those in the age-matched control saline 
group (PN19, 0.8 nM [3H]citalopram: F = 8.0, p = 0.03). The pound (#) and the dollar 
signs ($) denotes values which are significantly different from those in the age-matched 
ethanol saline and control buspirone, respectively (PNl 9, 2.4 nM [3H]citalopram: F = 7.1, 
p = 0.04). There was a significant ethanol x buspirone interaction (PN19, 0.8 nM 
[3H]citalopram: F = 6.4, p = 0.04). Abbreviations are the same as those in the Fig. 19. 
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c::::::::J CS ~ CB - ES ~ EB 
0.8nM CIT 2.4nM CIT 0.8nM CIT 2.4nM CIT 
PN 19 PN 35 
Fig. 24. Effects of buspirone treatment on the binding of [3H]citalopram in the 
striatum. Results are expressed as percent of the specific binding obtained from the 
control saline group at each age. The control saline values are given in Table 5. Statistical 
analysis was performed on the specific binding values. The asterisk (*) denotes values 
which are significantly different from those in the age-matched control saline group (at 
PN19, 0.8 nM [3H]citalopram: F = 8.7, p = 0.02; PN35, 2.4 nM [3H]citalopram: F =7.3, 
p = 0.04). The dollar sign($) denotes values which are significantly different from those 
in the age-matched control buspirone group (PN19, 0.8 nM [3H]citalopram: F = 8.7, p = 
0.02; PN35, 2.4 nM [3H]citalopram: F = 7.3, p = 0.04). Abbreviations are the same as 
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Fig. 25. Effects ofbuspirone treatment on the binding of [3H]citalopram in the dorsal 
raphe. Results are expressed as percent of the specific binding obtained from the control 
saline group at each age. The control saline values are given in Table 5. Statistical 
analysis was performed on the specific binding values. The asterisk (*) denotes values 
which are significantly different from those in the age-matched control saline group (F 
= 6.4, p = 0.045). Abbreviations are the same as those in the Fig. 19. 
89 
[::=J CS ~ CB - ES ~ EB 
120-----------------------------------------------, 
-Q) 



















0 ----O.SnM CIT 2.4nM CIT 
PN 19 
* * 
O.SnM CIT 2.4nM CIT 
PN 35 
Fig. 26. Effects of buspirone treatment on the binding of [3H]citalopram in the 
median raphe. Results are expressed as percent of the specific binding obtained from the 
control saline group at each age. The control saline values are given in Table 5. Statistical 
analysis was performed on the specific binding values. The asterisk (*) denotes values 
which are significantly different from those in the age-matched control saline group 
(PN19, 0.8 nM [3H]citalopram: F = 30.2, p = 0.027; PN35, 2.4 nM [3H]citalopram: F = 





















c::J CS fFA CB - ES ~ EB 
0.8nM CIT 2.4nM CIT 0.8nM CIT 2.4nMCIT 
PN 19 PN 35 
Fig. 27. Effects of buspirone treatment on the binding of [3H]citalopram in the CA3. 
Results are expressed as percent of the specific binding obtained from the control saline 
group at each age. The control saline values are given in Table 5. Statistical analysis was 
performed on the specific binding values. Abbreviations are same as those in the Fig. 19. 
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c::::::::J CS ~ CB - ES ~ EB 
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0.8nM CIT 2.4nMCIT 0.8nM CIT 2.4nMCIT 
PN 19 PN 35 
Fig. 28. Effects of buspirone treatment on the binding of [3H]citalopram in the 
amygdala. Results are expressed as percent of the specific binding obtained from the 
control saline group at each age. The control saline values are given in Table 5. Statistical 
analysis was performed on the specific binding values. Abbreviations are same as those 
in the Fig. 19. 
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The PH]-8-0H-DPAT binding study was also conducted in order to see whether 
maternal treatment with a 5-HT1A agonist, buspirone, prevents or reverses ethanol-
associated developmental abnormalities in 5-HT1A receptors. Table 6 contains the values 
for the specific binding of 1.0 nM and 2. 7 nM PHJ-8-0H-DPAT to brain sections 
obtained from the offspring of CS rats. The binding pattern of PHJ-8-0H-DPAT at PNl 9 
and PN35 was similar to that observed in earlier experiments (Table 3). The binding was 
high in the DG, DR, LS and low in the MnR, PCx and FCx. 
Compared to the binding in the offspring of CS, ethanol-exposed offspring had 
a transient increase of [3H]-8-0H-DPAT binding in the DG (Fig. 29) at PN19 and a 
decrease of binding in the PCx (Fig. 30) at PN35. These observations confirm the earlier 
findings. The binding in the DR (Fig. 31) and MnR (Fig. 32) was unaffected by in utero 
exposure in both the first and second experiments. The changes in the binding of [3H]-8-
0H-DP AT in the LS (Fig. 33) and FCx (Fig. 34) were significant in this experiment; a 
similar, though nonsignificant trend was found in the earlier investigation. 
Maternal treatment with buspirone appeared to prevent ethanol-associated 
developmental abnormalities in 5-HT1A receptors. Buspirone seemed to reverse the 
ethanol-associated increase in the binding of [3H]-8-0H-DPAT in the DG at PN19. 
Buspirone also appeared to prevent the decreased binding of either the 1.0 nM or 2. 7 nM 
[3H]-8-0H-DPAT in the PCx and LS of PN35 ethanol-exposed rats. Buspirone treatment 
during the embryonic period did not significantly affect the binding of PHJ-8-0H-DPAT 
in most brain regions examined in the postnatal rats. The only exception was found in 
the LS on PN35. 
TABLE6 
SPECIFIC BINDING OF [3H]-8-0H-DPAT IN THE CONTROL SALINE GROUP 
Specific binding (pmol/mg protein equivalent) 
l .OnM [3H]-8-0H-DPAT 2.7nM [3H]-8-0H-DPAT 
Region Age (n) (n) 
FCx PN19 0.081±0.065 (6) 0.095±0.040 (6) 
PN35 0.186±0.109 (6) 0.223±0.100 (6) 
PCx PN19 0.102±0.062 (6) 0.129±0.035 (6) 
PN35 0.214±0.096 (6) 0.212±0.058 (6) 
LS PN19 0.354±0.080 (7) 0.448±0.183 (7) 
PN35 0.472±0.182 (7) 0.634±0.200 (7) 
DG PN5 0.135±0.036 (5) 0.162±0.034 (8) 
PN19 0.485±0.135 (7) 0.512±0.170 (7) 
PN35 0.618±0.111 (7) 0. 722±0.132 (7) 
DR PN19 0.592±0.134 (5) 0.659±0.054 (5) 
PN35 0.659±0.145 (5) 0.745±0.265 (5) 
MnR PN19 0 .464±0 .104 (4) 0.429±0.074 (4) 
PN35 0.246±0.025 (4) 0.333±0.126 (4) 
All the data are presented as the mean ± SD. 
Abbreviations are same as in Table 3. 
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1.0nM DPAT 2.7nM DPAT 1.0nM DPAT 2.7nM DPAT 1.0nM DPAT 2.7nM DPAT 
PN5 PN19 PN35 
Fig. 29. Effects of buspirone treatment on the binding of [3H)-8-0H-DP AT in the 
dentate gyrus. Results are expressed as percent of the specific binding obtained from the 
control saline group at each age. The control saline values are given in Table 6. Statistical 
analysis was performed on the specific binding values. The asterisk (*) denotes values 
which are significantly different from those in the age-matched control saline group 
(PN19, 2.7 nM [3H]-8-0H-DPAT: F = 9.4, p = 0.02). Abbreviations are the same as those 
in the Fig. 19. 
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c=J CS ~ CB - ES ~ EB 
1.0nM DPAT 2.7nM DPAT 1.0nM DPAT 2.7nM DPAT 
PN 19 PN35 
Fig. 30. Effects of buspirone treatment on the binding of [3H]-8-0H-DPAT in the 
parietal cortex. Results are expressed as percent of the specific binding obtained from 
the control saline group at each age. The control saline values are given in Table 6. 
Statistical analysis was performed on the specific binding values. The asterisk (*) denotes 
values which are significantly different from those in the age-matched control saline 
group (PN35, 1.0 nM [3H]-8-0H-DPAT: F = 8.9, p = 0.03; PN35, 2.7 nM [3H]-8-0H-
DPAT: F = 8.5, p = 0.03). Abbreviations are the same as those in the Fig. 19. 
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CJ CS ~ CB - ES ~ EB 
1.0nM DPAT 2.7nM DPAT 1.0nM DPAT 2.7nM DPAT 
PN 19 PN 35 
Fig. 31. Effects of buspirone treatment on the binding of [3H]-8-0H-DP AT in the 
dorsal raphe. Results are expressed as percent of the specific binding obtained from the 
control saline group at each age. The control saline values are given in Table 6. Statistical 
analysis was performed on the specific binding values. Abbreviations are the same as 




















CJ CS f9JJ CB - ES ~ EB 
1.0nM DPAT 2.7nM DPAT 1.0nM DPAT 2.7nM DPAT 
PN 19 PN35 
Fig. 32. Effects of buspirone treatment on the binding of [3H]-8-0H-DPAT in the 
median rap he. Results are expressed as percent of the specific binding obtained from the 
control saline group at each age. The control saline values are given in Table 6. Statistical 
analysis was performed on the specific binding values. Abbreviations are the same as 
those in the Fig. 19. 
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1.0nM DPAT 2.7nM DPAT 
PN 19 
* 
1.0nM DPAT 2.7nM DPAT 
PN 35 
Fig. 33. Effects of buspirone treatment on the binding of [3H]-8-0H-DPAT in the 
lateral septum. Results are expressed as percent of the specific binding obtained from 
the control saline group at each age. The control saline values are given in Table 6. 
Statistical analysis was performed on the specific binding values. The asterisk (*) denotes 
values which are significantly different from those in the age-matched control saline 
group (PN35, 1.0 nM [3H]-8-0H-DPAT: F = 9.6, p = 0.02). Abbreviations are the same 
as those in the Fig. 19. 
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1.0nM DPAT 2.7nM DPAT 1.0nM DPAT 2.7nM DPAT 
PN 19 PN 35 
Fig. 34. Effects of buspirone treatment on the binding of [3H]-8-0H-DPAT in the 
frontal cortex. Results are expressed as percent of the specific binding obtained from the 
control saline group at each age. The control saline values are given in Table 6. Statistical 
analysis was performed on the specific binding values. The asterisk (*) denotes values 
which are significantly different from those in the age-matched control saline group 
(PN35, 1.0 nM [3H]-8-0H-DPAT: F = 9.6, p = 0.02). The pound(#) denotes values which 
are significantly different from those in the age-matched ethanol saline. There was a 
significant ethanol x buspirone interaction (PN35, 1.0 nM [3H]-8-0H-DPAT: F = 9.4, p 
= 0.03). Abbreviations are the same as those in the Fig. 19. 
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In Vitro Cell Culture Studies 
It was hypothesized that ethanol exerts some of its damaging effects on the 
developing serotonergic neurons by decreasing the concentration of serotonin and other 
essential trophic factors. The first portion of this dissertation discussed ethanol's effects 
on serotonergic neurons and the role of 5-HT1A receptors. This section concentrates on 
the effects of ethanol on trophic factors produced by astroglia. Astroglia from a target 
region (e.g. the cortex) were cultured in the presence or absence of 100 mM ethanol. 
The purity of the astroglial cultures was assessed by the presence of GF AP as shown Fig. 
35-A. Media from these astroglial cultures was collected. This media was assumed to 
contain trophic factors that were synthesized and secreted by astroglia. This conditioned 
media (CM) was then used at a concentration of 30% or 60% to culture control fetal 
rhombencephalic neurons, which contain the developing serotonergic neurons. 
Serotonergic neurons stained with 5-HT antibody are shown in Fig. 35-B. The effects of 
added CM (CCM or ECM) was noted on the development of several measurements of 
total neuronal development (cell number, DNA content, protein content, neurite 
outgrowth) and 5-HT neuronal development (5-HT immunopositive cells, 5-HT 
reuptake). 
The results of these studies demonstrate that addition of CM increased the 5-HT 
uptake (Fig. 36), total DNA content (Fig. 37), total number of surviving neurons (Fig. 
38) and the number of 5-HT immunopositive neurons (Fig. 39). CM also increased the 
number of neurons which had longer neurites (Fig. 40). These observations support the 
Fig. 35. Photographs of astroglial cells stained with GFAP antibody (A) and neuronal cells 
stained with 5-HT antibody (B). Cultures were stained with antibody as described in the Methods 
section. Cultures were photographed using a phase contrast microscope. 
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hypothesis that astroglia, derived from a target region, produce trophic factors which are 
necessary for normal neuronal development. 
When neuronal cultures maintained in CCM were compared with those 
maintained in ECM, several significant differences were noted. That is, neuronal 
cultures maintained in ECM have a decreased total DNA content (Fig. 37), total number 
of surviving neurons (Fig. 38) and number of neurons with longer neurites (Fig. 40). 
More importantly, the number of 5-HT immunopositive neurons (Fig. 39) and 5-HT 
reuptake (Fig. 40) were decreased in the cultures maintained in the ECM. In contrast, 
total protein content was not changed (Fig. 42). 
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Fig. 36. Dose-dependent effect of astroglial-derived conditioned media (CM) on 
neuronal [3H]5-HT uptake. Fetal rhombencephalic neurons were cultured in the presence 
of conditioned media obtained from astroglial cultures. Results are expressed as the 
percentage of the value in control cultures grown in chemically defined media. In the 
control cultures the mean uptake of [3H]5-HT was 0.226 pmol/well/20 min. The error bars 
represent the SD (n = 3 experiments. In each experiment 4 different wells were averaged 
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Fig. 37. Effects of CCM and ECM on total DNA content. Fetal rhombencephalic 
neurons were cultured in the presence of conditioned media obtained from astroglial 
cultures. CCM and ECM were derived from astroglial cultures grown for 4 days in the 
absence or presence of 100 mM ethanol. Results are expressed as the percentage of DNA 
in control cultures grown in chemically defined media (CDM). In the CDM cultures the 
mean DNA content was 2.99 µg/well. Each column and the error bar represent the mean 
± SD in one experiment. The findings were replicated in a second experiment. *p<0.05 
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Fig. 38. Effects of CCM and ECM on total cell number. Fetal rhombencephalic 
neurons were cultured in the presence of conditioned media obtained from astroglial 
cultures. CCM and ECM were derived from astroglial cultures grown for 4 days in the 
absence or presence of 100 mM ethanol. Results are expressed as the percentage of 
surviving cell number in the control cultures grown in chemically defined media (CDM). 
In the CDM cultures the mean was 4.47 x 104 cells/well. Each column and the error bar 
represent the mean ± SD in one experiment. The findings were replicated in a second 
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Fig. 39. Effects of CCM and ECM on the number of 5-HT immunopositive cells. 
Fetal rhombencephalic neurons were cultured in the presence of conditioned media 
obtained from astroglial cultures. CCM and ECM were derived from astroglial cultures 
grown for 4 days in the absence or presence of 100 mM ethanol. Results are expressed 
as the ratio of the number of 5-HT immunopositive cells to the total number of neurons. 
Each column and the error bar represent the mean ± SD in one experiment. The findings 
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Fig. 40. Effects of CCM and ECM on neurite length. Fetal rhombencephalic neurons 
were cultured in the presence of conditioned media obtained from astroglial cultures. 
CCM and ECM were derived from astroglial cultures grown for 4 days in the absence or 
presence of 100 mM ethanol. The longest neurite on each neuron was measured from cell 
body to the end of neurite. The results are expressed as the relative number of neurons 
which had a neurite length in the categories, less than 250 µm, 250 - 500 µm or greater 
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Fig. 41. Effects of CCM and ECM on neuronal [3H]5-HT uptake. Fetal 
rhombencephalic neurons were cultured in the presence of conditioned media obtained 
from astroglial cultures. CCM and ECM were derived from astroglial cultures grown for 
4 days in the absence or presence of 100 mM ethanol. Results are expressed as the 
percentage of the [3H]5-HT uptake in control cultures grown in chemically defined media 
(CDM). In the CDM cultures the mean [3H]5-HT uptake was 6.32 pmol/mg protein/20 
min. Each column and the error bar represent the mean ± SD in one experiment. The 
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Fig. 42. Effects of CCM and ECM on neuronal protein content. Fetal rhombencephalic 
neurons were cultured in the presence of conditioned media obtained from astroglial 
cultures. CCM and ECM were derived from astroglial cultures grown for 4 days in the 
absence or presence of 100 mM ethanol. Results are expressed as the percentage of 
protein in control cultures grown in chemically defined media (CDM). In the CDM 
cultures the mean protein content was 17.49 µg/well. Each column and the error bar 






The FAS model used in this dissertation included rats which were fed alcohol 
chronically before conception and throughout the gestation. Since maternal malnutrition, 
especially protein deficiency, is known to affect brain development (Druse et al., 1980; 
Smith and Druse, 1982), protein-rich, and nutritionally well-balanced diets (Norohona 
and Druse, 1982) were pair-fed to control and ethanol consuming rats. The comparable 
weight gains of mothers and of offspring in the pair-fed groups indicate that these two 
groups of rats were comparably nourished. Although the ad lib control rats consumed 
more diet and had a greater apparent weight gain during pregnancy, the weights of their 
offspring were not significantly different from those of the offspring of pair-fed control 
rats. Moreover, we rarely found any significant differences in terms of 5-HT reuptake 
and 5-HT1A binding sites between the offspring of pair-fed and ad lib control rats. 
Buspirone treatment did not affect diet consumption. This is consistent with a 
previous report in which subcutaneous injections of low doses of buspirone (up to 1.25 
mg/kg) increased food intake, but a higher dose (2.5 - 5 mg/kg) such as used in this 
study did not affect food consumption (Fletcher and Davies, 1990). Even though 
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buspirone-treated saline rats had a decreased maternal weight gain, the number of 
pups/litter and the pup weight were not different. 
Blood alcohol levels were in the physiological range for humans. Our values 
ranged from 75 to 120 mg/dl. In most states one is arrested for drunken driving with a 
BAL of 100 mg/dl or less. Since it has been recognized that heavier ethanol exposure 
leads to more severe effects in human FAS (Streissguth et al., 1988), one might expect 
higher BALs to cause more damage than that seen in our studies. 
5-HT Reuptake Sites and 5-HT1A Receptor Sites 
In order to quantitate the 5-HT nerve terminals, quantitative autoradiography 
(QAR) of PH]citalopram-labeled serotonin reuptake sites was used. 5-HT reuptake sites 
are highly localized on the 5-HT nerve terminals (Kuhar and Aghajanian, 1973) and 
citalopram selectively binds to the 5-HT reuptake sites (D 'Amato et al., 1987a; Duncan 
et al., 1992). Compared to binding assays using membrane homogenates, QAR provides 
improved localization and quantitation of reuptake sites in small, anatomically defined 
regions of the brain (Young and Kuhar, 1979; Palacios et al., 1981; Pazos and Palacios, 
1985). 
The 5-HT reuptake sites in the dorsal raphe seem to reach a peak density at about 
3 weeks after birth, and at this age the dorsal raphe contained the highest concentration 
of 5-HT reuptake sites among the regions (Pranzatelli and Martens, 1992). A dense patch 
of 5-HT reuptake sites was found in the parietal cortex at PN5 and PN19. This 
observation resembles the innervation pattern of 5-HT immunopositive fibers observed 
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by D' Amato et al. (1987b). 
Ligand binding was assessed at 2 concentrations; one concentration approximates 
the K0 and the second concentration was three times the K0 • Any changes of ligand 
binding at the concentration approximating K0 can potentially detect changes in the both 
affinity and density of receptors, whereas abnormalities detected at the higher 
concentration can detect changes only in the density of receptors. In some regions 
ethanol-associated differences are found at one but not both concentrations. However, 
generally a similar trend was found at the other ligand concentration, suggesting that 
perhaps a greater n was needed to demonstrate significance at other concentration. 
The results of quantitation of 5-HT reuptake sites showed that in the offspring 
of ethanol-fed rats 5-HT reuptake sites were increased in the dorsal raphe at PN5, and 
in the median raphe at PN19 and PN35. In contrast to those cell body regions, the 
reuptake sites were decreased in the frontal cortex, parietal cortex, lateral hypothalamus, 
substantia nigra, medial septum and striatum at PN19. The decreased 5-HT reuptake sites 
were also found in the lateral hypothalamus and substantia nigra at PN35. Ethanol-
associated changes of 5-HT reuptake sites in dorsal raphe, lateral hypothalamus and 
substantia nigra were consistently found in both the first and second investigation. The 
changes in the frontal cortex were significant in the second study; similar trends were 
found in the first study. In contrast, significant changes in the parietal cortex and median 
raphe may not be meaningful because the changes were only significant in one study and 
at only one concentration. The results of the first and second studies on 5-HT reuptake 
sites were summarized in Table 7. In a previous study from this laboratory, 5-HT 
114 
reuptake sites were measured in few, gross brain regions of the rat off spring (Druse and 
Paul, 1989). In that study, 5-HT uptake was decreased in the motor cortex of ethanol-
exposed rats at both PN19 and PN35. Similarly, decreased 5-HT reuptake sites in the 
frontal cortex were found in the present study. In addition, the present study considerably 
expands the earlier study by including many more regions and even including fetal brain 
tissue. 
5-HT reuptake sites were increased in the dorsal raphe of the ethanol-exposed 
rats. This finding could indicate 5-HT hyperinnervation (sprouting) due to the ethanol-
associated deficit of serotonin, because a similar hyperinnervation of 5-HT fibers has 
been observed in the brainstem of neonatal rats that have been treated with 5,7-DHT, a 
5-HT neurotoxin (Pranzatelli and Martens, 1992). 
In contrast to the raphe region, 5-HT reuptake sites were decreased in the 
terminal regions (e.g. frontal cortex, lateral hypothalamus, substantia nigra, medial 
septum and striatum). Decreased reuptake sites may indicate the delayed development of 
serotonergic fibers in ethanol-exposed rats. This is supported by the observations that the 
catch-up growth of 5-HT fibers was found in some regions at later ages. Delayed 
development may be caused by either decreased number of raphe 5-HT neurons, or 
decreased projections from raphe to target areas or both. In utero ethanol exposure has 
been demonstrated to decrease cell number in many regions such as somatosensory 
cortex, the hippocampal CA3 region and the cerebellum (Barnes and Walker, 1981; 
Bonthius and West, 1990; Miller and Potempa, 1990). Decreased 5-HT projections could 
be caused by either alterations in cell adhesion molecules (CAM) or altered levels of 
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trophic factors (e.g. 5-HT) or chemotactic factors which guide projecting nerve fibers. 
Interestingly, in the cell line (neurolastoma x glioma hybrid) ethanol inhibited the cell-
cell adhesion by altering the level of N-CAM and Ll (Charness et al., 1994). 
In utero ethanol may indirectly affect the development of 5-HT neurons possibly 
through the modulation of trophic factors, such as 5-HT. Previous studies from this 
laboratory as well as others demonstrated that serotonin content was decreased in the 
offspring of ethanol-exposed animals (Druse et al., 1991; Elis et al., 1976, 1978; 
Rathbun and Druse, 1985). More importantly, the decreased serotonin content was 
observed in the fetuses as early as ED15 in the brainstem and ED19 in the cortex (Druse 
et al., 1991). Fetal 5-HT acts as a developmental signal (Lauder, 1990). In addition to 
influencing growth cone elongation and neurite outgrowth to target areas (Haydon et al., 
1984, 1987), 5-HT has been demonstrated to regulate the normal development and 
maturation of serotonergic neurons in the fetal brain (Budnik et al., 1989; De Vitry et 
al., 1986; Whitaker-Azmitia and Azmitia, 1986; Whitaker-Azmitia et al., 1987). The 
effects of serotonin on its own neurons seem to be mediated through interaction with 5-
HT1A receptors (Whitaker-Azmitia and Azmitia, 1986; Whitaker-Azmitia et al., 1987). 
Treatment of pregnant rats with buspirone, a 5-HT1A receptor agonist, prevented the 
abnormal development of 5-HT terminals in the dorsal raphe (PN5), medial septum 
(PN19), frontal cortex (PN19), substantia nigra (PN35) and lateral hypothalamus (PN19 
and PN35) in the offspring of ethanol-exposed rats. This suggests that at least part of the 
abnormalities in the 5-HT terminal density induced by in utero ethanol exposure were 
due to decreased stimulation of 5-HT1A receptors. The effects of ethanol and buspirone 
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on citalopram binding to 5-HT reuptake sites were summarized in Table 7. These results 
are consistent with a previous report that the cortical deficit of 5-HT and its metabolite, 
5-HIAA, in ethanol-exposed offspring was prevented by maternal treatment with 
buspirone (Tajuddin and Druse, 1993). 
There could be possible mechanisms by which in utero ethanol alters 5-HT 
content. Serotonin synthesis depends on the concentration of tryptophan, the substrate for 
tryptophan hydroxy lase (Tong and Kaufman, 1975). The amount of tryptophan transport 
may be decreased, since ethanol impairs placental nutrient transport (Schenker, 1989). 
In utero ethanol exposure may indirectly affect 5-HT content by affecting other systems 
such as the production of corticosterone. Pregnant rats fed with alcohol-containing diet 
increased plasma corticosterone (Weinberg and Bezio 1987). It has been also shown that 
rats exposed to ethanol in utero have elevated plasma and brain corticosterone levels at 
birth (Kakihana et al., 1980; Taylor et al., 1982a). Alteration of corticosterone level in 
fetus as well as mother may affect the normal development of tryptophan hydroxylase, 
a serotonin synthesizing enzyme since corticosterone is required for the normal 
development of tryptophan hydroxylase (Sze, 1980). 
The results of the present experiments also indicate that in utero ethanol exposure 
has region- and age-specific effects on the development of 5-HT fibers. Similar region-
specific effects of in utero ethanol exposure have been observed in the hippocampus. 
Hippocampal pyramidal cells in the CAI region are decreased by prenatal ethanol 
exposure, whereas the cells in the CA3 region were not affected (Barnes and Walker, 
1981). The present studies also indicate that many of the detected developmental 
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abnormalities are transient. Transient, age-specific ethanol effects have also been 
demonstrated in the cerebellum (Volk, 1977). 
In some regions (e.g. the parietal cortex and striatum) buspirone did not prevent 
or reverse the abnormalities of 5-HT terminal density. This may be due to differences 
between the timing of the buspirone treatment (ED13 to ED21) and key developmental 
processes in the unaffected regions. Alternatively, ethanol-associated 5-HT terminal 
abnormalities in these regions may be due to factors other than the fetal deficit of 
serotonin. In utero ethanol exposure may affect the production of trophic factors, which 
consequently affect the development of 5-HT terminals. This effect may be mediated by 
ethanol's action on astroglial cells. Astroglial cells are known to produce growth factors 
which are essential for the neuronal survival and differentiation during brain development 
(Manthorpe et al., 1986). 
The development of postsynaptic 5-HT1A receptors were increased in the dentate 
gyros at PN19 and decreased in the parietal cortex at PN35 by ethanol exposure in utero. 
In contrast, the development of 5-HT1A receptors in the raphe at both PN19 and PN35 
was not affected. Although the binding of PH]-8-0H-DPAT in the raphe regions of the 
fetal brain was not measurable in this study, membrane homogenate binding studies from 
this laboratory demonstrated that the binding of 10 nM [3H]-8-0H-DPAT was 
significantly increased in ethanol-exposed rat fetuses on ED19 (Druse et al., 1991). Thus, 
in utero ethanol exposure adversely affects the developmental pattern of 5-HT1A receptors. 
Decreased fetal serotonin may contribute to the developmental abnormalities in 
5-HT1A receptors. This hypothesis is supported by studies that found delayed 5-HT target 
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differentiation in the offspring brain, when pregnant rats were treated with pCPA, a 5-
HT synthesis inhibitor (Lauder and Krebs, 1978). The expression of 5-HT1 receptors in 
those offspring was affected in both brainstem and forebrain regions (Whitaker-Azmitia 
et al., 1987). However, buspirone treatment during the embryonic period did not always 
prevent the effects of in utero ethanol exposure on 5-HT1A receptors. Table 8 summarized 
the effects of ethanol and buspirone on 8-0H-DPAT binding to 5-HT1A receptors. This 
suggests that the abnormal development of 5-HT1A receptors in ethanol-exposed rats may 
be due to more than the decreased stimulation of 5-HT1A receptors on developing raphe 
neurons. There may also be altered levels of other trophic factors such as astroglial-
derived growth factors or decreased stimulation of other fetal brain 5-HT receptors (e. 
g. 5-HT2 receptors). 
The mechanism by which buspirone exerts its effects on the fetal brain is 
presently unknown. However, the effects of buspirone in the adult brain are mediated 
through its interaction with 5-HT1A receptors. Buspirone binds to 5-HT1A receptors with 
high affinity as indicated by an IC50 of 9.5 nM for displacing PH]-8-0H-DPAT 
(Peroutka, 1985). In addition, the binding pattern of in vivo PH]buspirone 
autoradiography is remarkably similar to the distribution pattern of 5-HT1A receptors 
(Matheson and Tunnicliff, 1991). Electrophysiological, biochemical and pharmacological 
studies demonstrated that buspirone acts as a full agonist on the 5-HT1A receptors of 
serotonergic dorsal raphe neurons (Meller et al., 1990; VanderMaelen et al., 1986). In 
the hippocampus buspirone acts as a partial agonist on the postsynaptic 5-HT1A receptors 
(Andrade and Nicoll, 1987; Yocca et al., 1986). Since 5-HT1A receptors and mRNA are 
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present in the fetal rat brain (Daval et al., 1987; Hillion et al., 1990), the effects of 
maternal buspirone treatment are presumably mediated through its action on fetal 5-HT1A 
receptors. Buspirone not only acts on the neuronal receptors, but may also act on the 
astroglial 5-HT1A receptors, whose activation stimulates the production of serotonergic 
growth factors, such as SlOOJ} (Azmitia et al., 1990; Whitaker-Azmitia and Azmitia, 
1989; Whitaker-Azmitia et al., 1990). 
There is also the possibility that the effects of buspirone could be mediated 
through other neurotransmitter systems. Although its binding affinity to D2 receptors is 
low as indicated by an IC50 of 260 nM for displacement of [3H]spiperone from striatal 
membranes (Riblet et al., 1982), buspirone can act on dopamine D2 receptors as an 
antagonist. The latter effect consequently increases dopaminergic neurotransmission 
(Riblet et al., 1984). One also can not exclude the possibility that buspirone treatment 
elevates maternal ACTH, corticosterone and prolactin (Gilbert et al., 1988; 
Montefrancesco et al., 1990; Meltzer et al., 1991), and that these changes contribute to 
the protective effects of buspirone. In fact, ACTH stimulates the development of 
serotonergic neurons in culture (Davila et al., 1986). 
Effects of Astroglial Cells on the Survival and 
Differentiation of 5-HT Neurons In Vitro 
During brain development astroglial cells play an important role in the proper 
maturation of the nervous system. For example, radial glial cells guide the migration of 
immature neurons (Rakic, 1972). Astroglial cells secrete soluble molecules which are 
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essential for neuronal growth and survival (Banker, 1980; Kadle et al., 1988; Lieth et 
al., 1989; Manthorpe et al., 1986; Muller and Seifert, 1982). Prenatal exposure to 
ethanol induces premature degradation of the network of radial glial fibers in the cortex 
(Miller and Robertson, 1993). 
Ethanol exposure has been shown to alter the function of astroglial cells. For 
example, ethanol decreases glutamine synthetase activity in astroglial cells (Babu et al., 
1994; Davies and Vernadakis, 1984) as well as hexose uptake (Singh et al., 1990). It 
appears that astroglial cells are more susceptible to ethanol than neurons in terms of their 
function (Babu et al., 1994; Davies and Vernadakis, 1984; Guerri et al., 1990; Snyder 
et al., 1992). When rhombencephalic astroglial cells and neurons were cultured in a 
serum-containing media, ethanol decreased rhombencephalic astroglial protein content 
and astroglial 5-HT uptake (Lokhorst and Druse, 1993b), while having no effect on the 
rhombencephalic neuronal protein and 5-HT uptake (Lokhorst and Druse, 1993b). In 
addition, glutamine synthetase activity was decreased in the astroglial cells derived from 
the ethanol-treated rats, whereas the neuron specific enolase activity was not affected in 
the neurons derived from the same animal (Babu et al., 1994). The ethanol-associated 
decrement in astroglial protein content and synthesis may be indicative of decreased 
astroglial production of neurotrophic factors. 
The results of the present cell culture study indicate that conditioned media (CM), 
derived from target astroglia, contained neuronal growth factors since CM enhanced the 
number of neurons and 5-HT immunopositive neurons, total DNA content, and 5-HT 
uptake. The effect of CM on 5-HT immunopositive neurons and serotonin uptake suggest 
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that target astroglial cells produce growth factors essential for serotonergic neurons as 
well as other neurons. 
Total number of neurons, total DNA content and the number of 5-HT 
immunopositive neurons were decreased in the cultures grown in the conditioned media 
derived from astroglial cells treated with 100 mM ethanol for 4 days (ECM). Serotonin 
uptake was also decreased in the cultures grown in the ECM. The cultures showed a 
disturbed pattern of neurite outgrowth; the relative number of neurons having medium 
length neurites was decreased. This demonstrates that astroglial exposure to ethanol 
decreases the astroglial production of growth factors which are involved with neuronal 
survival and growth. The possible neurotrophic factors which could be affected by 
ethanol include SlOOB, fibroblast growth factor (FGF), epidermal growth factor (EGF) 
and insulin-like growth factors I and II (IGF-1 & IGF-11). SlOOB is synthesized and 
secreted mainly by astrocytes and acts on CNS neurons (reviewed by Walicke, 1989). 
Serotonergic neurons are among those which respond to SlOOB. FGF appears to be 
synthesized by astrocytes (Ferrara et al., 1988). Basic FGF (bFGF) has been shown to 
promote neuron survival and neurite extension in hippocampal (Walicke et al., 1986), 
cortical (Morrison et al., 1986) and mesencephalic neurons (Ferrari et al., 1989) in vitro. 
EGF immunoreactivity and EGF receptors have been demonstrated in the frontal and 
parietal cortex, and striatum of developing rats (Fallon et al., 1984; Quirion et al., 
1988). EGF promotes the maturation of telencephalic neurons (Monnet-Tschudi and 
Honegger, 1989). The receptors for IGF-1 and IGF-11 are found in fetal and adult 
mammalian brain (reviewed by Baskin et al., 1988). IGF-1 promotes survival and neurite 
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outgrowth of fetal hypothalamic neurons (Torres-Aleman et al., 1990). 
There are several possible mechanisms by which ethanol affects astroglial 
function, including the production of growth factors. Chronic ethanol exposure has been 
shown to alter phosphoinositide (Pl) hydrolysis in astrocytes (Ritchie et al., 1988). PI 
hydrolysis generates diacylglycerol which functions as an essential cofactor for protein 
kinase C, and inositol triphosphate which regulates ca+2 mobilization. Thus, altered PI 
hydrolysis may lead to the alteration of Ca +2 and protein kinase C levels. Both Ca +2 and 
protein kinase C are important mediators of cell proliferation and differentiation 
(reviewed by Clapham, 1995; Clemens et al., 1992; Nishizuka, 1992; Rosen et al., 1995; 
Whitaker, 1995). Cytosolic ca+2 levels seem to be quantitatively correlated with 
transcription factor expression (Negulescu et al., 1994). Intracellular Ca+2 levels are also 
involved in cell death such as programmed cell death (Nicotera et al., 1994) and 
excitotoxicity (Schanne et al., 1979; Dugan and Choi, 1994). Therefore, effects of 
ethanol on the alteration of PI hydrolysis may be ultimately involved in gene regulation 
and/or cell death. Ethanol may alter gene regulation by acting through alterations of 
second messengers, and by disturbing gene transcription. In fact, ethanol exposure has 
been shown to increase the transcription rate of the stress protein Hsc70 and tyrosine 
hydroxylase in neural cell lines in culture (Miles et al., 1991; Gayer et al., 1991). In 
primary cultures of cortical astrocytes ethanol has been also shown to increase the GF AP 
mRNA levels (Fletcher and Shain, 1993). 
Concluding Remarks 
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The present study demonstrates that in utero ethanol exposure adversely affects 
the development of 5-HT reuptake sites and 5-HT1A receptors. This study also 
demonstrates that ethanol exposure decreases astroglial production of neurotrophic 
factors. Maternal treatment with buspirone, a 5-HT1A agonist, has been shown in this and 
a prior study to overcome or prevent some of the damaging effects of ethanol. Therefore, 
the mechanism by which ethanol causes these abnormalities may be due partly to the 
decreased stimulation of 5-HT1A receptors and decreased production of astroglial cell-
derived growth factors that are essential for normal development of 5-HT and other 
neurons. Decreased stimulation of raphe 5-HT1A receptors may result in altered 
development of 5-HT terminals as seen in altered 5-HT reuptake sites. Decreased 
stimulation of astroglial 5-HT1A receptors potentiates the ethanol effect on the decreased 
production of astroglial cells. 
However, additional studies are needed to assess buspirone's effects on other 
neurotransmitter systems which were affected by in utero ethanol exposure. In addition, 
more studies are needed to address the mechanism by which in utero ethanol exposure 
decreases the serotonin content and astroglial growth factors in the fetal brain. A 
schematic diagram summarizing the postulated action mechanism of ethanol and 
buspirone is presented in Fig. 43. 
TABLE 7 
EFFECTS OF ETHANOL AND BUSPIRONE ON CITALOPRAM BINDING TO 5-HT 
REUPTAKE SITES 
0.8 nM 2.4nM 
Region Age Study 1 Study 2 Buspirone Study 1 Study 2 Buspirone 
FCx PN19 -.!.- .i -.!.- .i 
PN35 -.!.-
PCx PN5 
PN19 .i .i 
PN35 
MS PN19 .i .i .i .i 
PN35 




LH PN19 .i .i .i .i .i 
PN35 .i .i .i -.!.-
AMG PN19 
PN35 
SN PN19 -.!.- .i .i .i .i .i 
PN35 .i .i -.!.-
DR ED19 -t- t 
PN5 t -t- -t- t 
PN19 
PN35 
MnR PN19 t 
PN35 t t t 
The solid arrows ct' .i) indicate that values from ethanol-exposed offspring were significantly different from 
those of control saline-treated offspring (P < 0.05). The broken arrows (-t-, -.!.-) indicate nonsignficant 
trends (P > 0.05). The dotted lines (---) are used to demonstrate that in utero ethanol exposure had no effect 
on 5-HT reuptake sites. Abbreviations are same as in Table 5. 
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TABLE 8 























1.1 nM 2.75 nM 
Study 1 Study 2 Buspirone Study 1 Study 2 Buspirone 
"' 
-t- t t t t 
This table summarizes the results obtained in two experiments in which [3H)-8-0H-DPAT was 
used to radiolabel 5-HT1A receptors. The solid arrows (t, t) indicate that values from ethanol-
exposed offspring were significantly different from those of control saline-treated offspring (P < 
0.05). The broken arrows (-t-, -t-) indicate nonsignficant trends (P > 0.05). The dotted lines 
(---) are used to demonstrate that in utero ethanol exposure had no effect on 5-HT IA receptors. 





Fig. 43. Proposed action mechanisms of ethanol and buspirone on the serotonergic 
system. Ethanol decreases serotonin content and astroglial production of neurotrophic 
factors. Decreased serotonin less stimulates raphe 5-HT1A receptors, which results in 
altered development of serotonergic fibers. Decreased serotonin also less stimulates 
astroglial 5-HT IA receptors, which potentiates ethanol's effect on the decreased production 
of neurotrophic factors. Buspirone prevents ethanol-associated abnormal development of 
serotonergic fibers by stimulating both raphe and astroglial 5-HT1A receptors. However, 
further studies are required for the effects of buspirone acting on D2 receptors as an 
antagonist, which, in turn, affects the development of 5-HT fibers. Abbreviations are as 




STATISTICAL SIGNIFICANCE LEVEL OF BINDING ASSAY RESULTS 
Figure Region Age [Ligand] F-ratio P value 
[3H)Citalopram 
3 DR PN 5 0.8 nM 19.4 0.0004 
2.4 nM 2.6 0.12 
PN19 0.8 nM 0.1 0.9 
2.4 nM 2.6 0.1 
PN35 0.8 nM 1.4 0.3 
2.4 nM 0.4 0.7 
4 MnR PN19 0.8 nM 1.2 0.3 
2.4 nM 0.6 0.6 
PN35 0.8 nM 7.7 0.0071 
2.4 nM 0.4 0.7 
5 LH PN19 0.8 nM 12.2 0.001 
2.4 nM 8.2 0.006 
PN35 0.8 nM 5.3 0.02 
2.4 nM 12.1 0.0013 
6 SN PN19 0.8 nM 2.4 0.1 
2.4 nM 6.6 0.01 
PN35 0.8 nM 17.8 0.0005 
2.4 nM 2.9 0.09 
7 Amygdala PN19 0.8 nM 0.2 0.8 
2.4 nM 1.3 0.3 
PN35 0.8 nM 1.2 0.3 
2.4 nM 1.4 0.3 
8 CA3 PN19 0.8 nM 0.1 0.9 
2.4 nM 0.7 0.5 
PN35 0.8 nM 0.8 0.5 
2.4 nM 0.2 0.8 
9 PCx PN5 0.8nM 0.1 0.9 
2.4 nM 0.3 0.8 
PN19 0.8 nM 0.3 0.8 
2.4 nM 1.5 0.3 
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Figure Region Age [Ligand] F-ratio P value 
PN35 0.8 nM 1.4 0.3 
2.4 nM 0.1 0.9 
10 FCx PN19 0.8 nM 0.9 0.43 
2.4 nM 1.3 0.3 
PN35 0.8 nM 0.6 0.6 
2.4 nM 1.5 0.3 
[ 3H)-80H-DPAT 
12 DG PN5 1.1 nM 3.8 0.6 
2.75 nM 2.0 0.2 
PN19 1.1 nM 1.0 0.4 
2.75 nM 4.0 0.05 
PN35 1.1 nM 0.4 0.7 
2.75 nM 0.1 0.9 
13 PCx PN19 1.1 nM 1.0 0.4 
2.75 nM 1.4 0.3 
PN35 1.1 nM 4.2 0.04 
2.75 nM 4.3 0.04 
14 FCx PN19 1.1 nM 0.2 0.8 
2.75 nM 1.7 0.2 
PN35 1.1 nM 1.9 0.2 
2.75 nM 1.2 0.3 
15 LS PN19 1.1 nM 1.3 0.3 
2.75 nM 1.0 0.4 
PN35 1.1 nM 0.4 0.7 
2.75 nM 2.0 0.2 
16 DR PN19 1.1 nM 2.3 0.2 
2.75 nM 1.3 0.3 
PN35 1.1 nM 0.1 0.9 
2.75 nM 0.3 0.8 
17 MnR PN19 1.1 nM 0.9 0.5 
2.75 nM 0.6 0.6 
PN35 1.1 nM 0.7 0.5 
2.75 nM 1.9 0.2 
129 
Figure Region Age [Ligand] Group F-ratio P value 
[ 3H]Citalopram 
19 FCx PN19 0.8 nM Ethanol 4.2 0.09 
Buspirone 0.3 0.6 
Interaction 2.8 0.1 
2.4 nM Ethanol 1.3 0.3 
Buspirone 0.002 1.0 
Interaction 7.0 0.045 
PN35 0.8 nM Ethanol 0.5 0.5 
Buspirone 2.0 0.2 
Interaction 2.3 0.2 
2.4 nM Ethanol 0.5 0.5 
Buspirone 0.03 0.9 
Interaction 0.9 0.4 
20 PCx PN5 0.8 nM Ethanol 0.5 0.5 
Buspirone 0.3 0.6 
Interaction 1.5 0.3 
2.4nM Ethanol 0.4 0.6 
Buspirone 0.4 0.6 
Interaction 0.2 0.6 
PN19 0.8 nM Ethanol 8.7 0.03 
Buspirone 0.6 0.5 
Interaction 0.1 0.8 
2.4 nM Ethanol 0.04 0.8 
Buspirone 0.2 0.7 
Interaction 0.03 0.9 
PN35 0.8 nM Ethanol 0.03 0.9 
Buspirone 1.4 0.3 
Interaction 2.2 0.2 
2.4 nM Ethanol 0.3 0.6 
Buspirone 0.9 0.4 
Interaction 1.8 0.2 
21 LH PN19 0.8 nM Ethanol 13.7 O.Ql 
Buspiron 2.3 0.2 
Interaction 9.8 0.02 
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Figure Region Age [Ligand] Group F-ratio P value 
2.4 nM Ethanol 7.4 0.03 
Buspirone 0.1 0.7 
Interaction 0.1 0.7 
PN35 0.8 nM Ethanol 1.7 0.2 
Buspirone 12.5 O.Ql 
Interaction 11.6 O.Ql 
2.4 nM Ethanol 1.83 0.2 
Buspirone O.Ql 0.9 
Interaction 2.2 0.2 
22 SN PN19 0.8 nM Ethanol 27.0 0.002 
Buspirone 0.2 0.6 
Interaction 0.99 0.4 
2.4 nM Ethanol 12.1 O.Ql 
Buspirone 0.2 0.7 
Interaction 3.8 O.l 
PN35 0.8 nM Ethanol 5.9 0.05 
Buspirone 3.8 0.1 
Interaction 1.0 0.4 
2.4 nM Ethanol 20.4 0.004 
Buspirone 0.5 0.4 
Interaction 0.17 0.7 
23 MS PN19 0.8 nM Ethanol 8.0 0.03 
Buspirone 0.3 0.6 
Interaction 6.4 0.04 
2.4 nM Ethanol 5.7 0.05 
Buspirone 7.1 0.04 
Interaction 2.3 0.2 
PN35 0.8 nM Ethanol 0.05 0.8 
Buspirone 0.7 0.4 
Interaction 0.5 0.5 
2.4 nM Ethanol 0.4 0.5 
Buspirone 1.1 0.3 
Interaction O.l 0.8 
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Figure Region Age [Ligand] Group F-ratio P value 
24 Stria tum PN19 0.8 nM Ethanol 8.7 0.03 
Buspirone 1.3 0.3 
Interaction 0.5 0.5 
2.4 nM Ethanol 38.7 0.0008 
Buspirone 0.003 0.96 
Interaction 0.1 0.8 
PN35 0.8 nM Ethanol 0.03 0.9 
Buspirone 0.3 0.6 
Interaction 0.4 0.6 
2.4 nM Ethanol 7.3 0.04 
Buspirone 3.3 0.1 
Interaction 0.3 0.6 
25 DR ED19 0.8 nM Ethanol 0.01 0.9 
Buspirone 0.9 0.4 
Interaction 0.6 0.5 
2.4 nM Ethanol 0.05 0.8 
Buspirone 0.3 0.6 
Interaction 0.4 0.5 
PN5 0.8 nM Ethanol 4.3 0.1 
Buspirone 1.9 0.2 
Interaction 0.3 0.6 
2.4 nM Ethanol 6.4 0.045 
Buspirone 0.2 0.7 
Interaction 1.4 0.3 
PN19 0.8 nM Ethanol 0.8 0.4 
Buspirone 0.5 0.5 
Interaction 0.5 0.5 
2.4 nM Ethanol 0.3 0.6 
Buspirone 0.0002 0.99 
Interaction 1.8 0.2 
PN35 0.8 nM Ethanol 0.08 0.8 
Buspirone 0.001 0.98 
Interaction 5.0 0.07 
2.4 nM Ethanol 3.0 0.1 
Buspirone 0.9 0.4 
Interaction 0.002 0.97 
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Figure Region Age [Ligand] Group F-ratio P value 
26 MnR PN19 0.8 nM Ethanol 0.2 0.7 
Buspirone 2.2 0.2 
Interaction 2.2 0.2 
2.4 nM Ethanol 30.2 0.003 
Buspirone 0.00 0.999 
Interaction 4.6 0.09 
PN35 0.8 nM Ethanol 9.3 0.02 
Buspirone 1.9 0.2 
Interaction 2.2 0.2 
2.4 nM Ethanol 0.4 0.5 
Buspirone 0.2 0.7 
Interaction 0.007 0.9 
27 CA3 PN19 0.8 nM Ethanol 2.5 0.2 
Buspirone 0.2 0.7 
Interaction 0.1 0.7 
2.4 nM Ethanol 0.06 0.8 
Buspirone 0.08 0.8 
Interaction 0.0097 0.9 
PN35 0.8 nM Ethanol 0.3 0.6 
Buspirone 0.02 0.9 
Interaction 0.5 0.5 
2.4 nM Ethanol 0.6 0.5 
Buspirone 0.2 0.7 
Interaction 0.3 0.6 
28 Amygdala PN19 0.8 nM Ethanol 4.4 0.08 
Buspirone 8.6 0.03 
Interaction 0.2 0.7 
2.4 nM Ethanol 32.0 0.001 
Buspirone 0.0053 0.9 
Interaction 0.0083 0.9 
PN35 0.8 nM Ethanol 0.2 0.7 
Buspirone 0.03 0.9 
Interaction 0.9 0.4 
2.4 nM Ethanol 0.4 0.5 
Buspirone 0.07 0.8 
Interaction 0.09 0.8 
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Figure Region Age [Ligand] Group F-ratio P value 
[ 3H]-8-0H-DP AT 
29 DG PN5 1.0 nM Ethanol 0.1 0.7 
Buspirone 1.8 0.2 
Interaction 0.6 0.5 
2.7nM Ethanol 0.09 0.8 
Buspirone 0.5 0.5 
Interaction 0.5 0.5 
PN19 1.0 nM Ethanol 5.0 0.07 
Buspirone 0.8 0.4 
Interaction 2.5 0.2 
2.7nM Ethanol 9.4 0.02 
Buspirone 0.07 0.8 
Interaction 2.02 0.2 
PN35 1.0 nM Ethanol 0.2 0.7 
Buspirone 0.04 0.8 
Interaction 0.2 0.7 
2.7 nM Ethanol 0.03 0.9 
Buspirone 0.4 0.6 
Interaction 0.2 0.7 
30 PCx PN19 1.0 nM Ethanol 0.3 0.6 
Buspirone 0.2 0.7 
Interaction 0.3 0.6 
2.7 nM Ethanol 1.3 0.3 
Buspirone 6.7 0.05 
Interaction 0.8 0.4 
PN35 1.0 nM Ethanol 8.9 0.03 
Buspirone 1.4 0.3 
Interaction 3.0 0.1 
2.7 nM Ethanol 8.5 0.03 
Buspirone 3.4 0.1 
Interaction 2.8 0.2 
31 DR PN19 1.0 nM Ethanol 0.3 0.6 
Buspirone 0.04 0.8 
Interaction 0.6 0.5 
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Figure Region Age [Ligand] Group F-ratio P value 
2.7 nM Ethanol 2.8 0.1 
Buspirone 0.5 0.5 
Interaction 0.2 0.7 
PN35 1.0 nM Ethanol 0.0004 0.98 
Buspirone 0.2 0.6 
Interaction 0.1 0.7 
2.7 nM Ethanol 0.4 0.5 
Buspirone 0.6 0.5 
Interaction 0.1 0.7 
32 MnR PN19 1.0 nM Ethanol 0.32 0.58 
Buspirone 0.119 0.74 
Interaction 0.7 0.4 
2.7 nM Ethanol 0.006 0.9 
Buspirone 0.1 0.7 
Interaction 0.1 0.8 
PN35 1.0 nM Ethanol 0.4 0.5 
Buspirone 0.2 0.7 
Interaction 0.007 0.9 
2.7nM Ethanol 0.2 0.7 
Buspirone 0.03 0.9 
Interaction 0.00 0.998 
33 LS PN19 1.0 nM Ethanol 0.02 0.9 
Buspirone 0.4 0.6 
Interaction 1.7 0.2 
2.7nM Ethanol 0.02 0.9 
Buspirone 0.03 0.9 
Interaction 3.9 0.1 
PN35 1.0 nM Ethanol 9.6 0.02 
Buspirone 0.003 0.96 
Interaction 6.8 0.04 
2.7 nM Ethanol 0.9 0.4 
Buspirone 2.4 0.2 
Interaction 20.0 0.0042 
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Figure Region Age [Ligand] Group F-ratio P value 
34 FCx PN19 1.0 nM Ethanol 0.004 0.96 
Buspirone 0.3 0.6 
Interaction 2.9 0.2 
2.7 nM Ethanol 0.4 0.5 
Buspirone 0.2 0.6 
Interaction 4.4 0.09 
PN35 1.0 nM Ethanol 0.9 0.4 
Buspirone 4.2 0.1 
Interaction 9.4 0.03 
2.7 nM Ethanol 0.4 0.5 
Buspirone 1.7 0.2 
Interaction 1.8 0.2 
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